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ABSTRACT 
 
 
This study, in non-human primates (Papio ursinus), evaluated the healing potential 
of recombinant human transforming growth factor-3 (rhTGF-3) when implanted 
in exposed periodontal furcation defects either by direct application to the defect or 
by transplantation of rhTGF-3-instigated heterotopic bone as source of 
autogenous bone.  Class II furcation defects were surgically created bilaterally in 
the first and second molars of both the mandible and the maxilla of four clinically 
healthy adult baboons.  Simultaneously, autogenous bone was induced bilaterally 
within the rectus abdominis muscle of the baboons using rhTGF-3.  Forty days 
later, the periodontal defects were implanted with rhTGF-3 in Matrigel® as 
delivery system, or rhTGF-3 plus muscle tissue in Matrigel®, or with the 
harvested rhTGF-3-induced autogenous bone.  Sixty days after periodontal 
implantation, the animals were euthanased and the molars harvested together with 
the surrounding tissue.  Histological analysis was performed by light microscopy 
and digital imaging computer software.  The extent of regeneration was assessed 
by measuring area and volume of new alveolar bone, height of new alveolar bone 
and height of new cementum.  The results, compared to controls, showed 
pronounced periodontal tissue regeneration in experimental defects.  The most 
noteworthy healing was observed in defects implanted with heterotopically 
induced autogenous bone as well as those implanted with rhTGF-3 plus muscle 
tissue.  The findings of this study suggest that rhTGF-3 applied directly to a 
defect, or rhTGF-3-induced autogenous bone, transplanted to a defect, have 
significant regenerative capabilities in periodontal tissue regeneration of non-
human primates Papio ursinus. 
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1. INTRODUCTION 
 
 
 
Periodontal disease has been with mankind since time immemorial.  Evidence of 
pre-pubertal periodontitis was identified in a 3-million-year-old fossilized maxilla 
of the early hominid, Australopithecus africanus (Ripamonti, 1988) and severe 
bone loss compatible with periodontitis was noted in the fossilized remains of 
Homo heidelbergensis in Mauer, Germany (Czarnetzki et al., 2003). 
  
Periodontal disease is characterized by inflammation of gingivae and adjacent 
dental attachment apparatus and is caused by subgingival colonization of oral 
pathogens (Anusaksathien and Giannobile, 2002), which inhabit dental plaque.  
Gingivitis, as the earliest indication of periodontitis, may be a separate disease, 
which in some patients will not advance to periodontitis (Listgarten et al., 1985; 
Matthews, 2000).   
 
Gingival diseases may be plaque-induced or non-plaque-induced gingival lesions 
(Armitage, 1999; Wiebe and Putnins, 2000; Kojovi and Kesi, 2003).  The latter 
include gingival diseases of specific bacterial origin such as Neisseria gonorrhea, 
Treponema pallidum and streptococci and those of viral origin such as herpetic 
gingivostomatitis (Armitage, 1999), which is a primary infection by the herpes 
simplex virus occurring mainly in infants (Keys and Bartold, 2000).  Plaque-
induced gingivitis is the most common form of gingivitis (Page, 1986; Coventry, 
2000) and includes systemic factors associated with the endocrine system, certain 
medications and malnutrition (Armitage, 1999; Kojovi and Kesi, 2003). 
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The pathogenesis of periodontitis is dependent on the interactions between host 
and micro-organism and may be complicated by genetic and environmental risk 
factors (Matthews, 2000; Kantarci and van Dyke, 2002).  The development of 
periodontitis is associated with the progression of predominantly gram-positive 
bacterial flora to gram-negative anaerobes (Tanner et al., 1979; Holt and Bramanti, 
1991; Duncan et al., 1996).  A limited number of gram-negative species have been 
consistently linked with specific forms of periodontal disease:  Porphyromonas 
gingivalis with chronic and severe adult periodontitis, and Actinobacillus 
actinomycetemcomitans with localized juvenile periodontitis (Haffajee and 
Socransky, 1994; Michalowicz et al., 2000;  Duncan et al., 2003;  Pussinen et al., 
2003) and Prevotella intermedia and spirochaetes such as Treponema denticola 
(Haffajee and Socransky, 1994; Duncan et al., 2003) with acute necrotizing 
ulcerative gingivitis.   
 
Periodontal tissue regeneration is the restoration of tooth-supporting structures of 
the periodontium, including alveolar bone, cementum and periodontal ligament 
(Nevins et al., 2003).  The process depends on the migration, adhesion, 
proliferation and differentiation of periodontal ligament fibroblasts (Pitaru et al., 
1984), which are the predominant cells of the soft connective tissue of the 
periodontium (McCulloch and Bordin, 1991; McCulloch, 1995) and which play a 
leading role in the homeostasis and regeneration of periodontal tissue (McCulloch, 
1995; Miguel et al., 2003). 
 
Over the years, predictable and complete tissue regeneration of lost or damaged 
periodontium has remained the ultimate goal in periodontal surgical techniques.  
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Studies in animals and humans have demonstrated the potential for achieving this 
seemingly elusive objective.  To date, regenerative techniques have included bone 
graft, root surface conditioning, guided tissue regeneration (GTR) and the use of 
osteogenic growth factors. 
 
Bone Grafts  
Bone grafts are used in advanced stages of periodontal destruction where the 
underlying alveolar bone has been severely depleted.  There are several types of 
bone grafts that may be used in periodontal tissue regeneration, namely autogenous 
bone, allografts, alloplastic materials and xenografts.  Autogenous bone is 
transplanted from one site to another within the same patient.  It may be obtained 
from an extra-oral site such as the iliac crest or from an intra-oral site such as a 
healed extraction site.  Disadvantages associated with using autogenous bone are 
the limited quantities of material available, donor site morbidity and the added 
discomfort for the patient of a second surgical site.  Allografts are transplants 
between the same species and are subject to graft rejection as well as the transfer of 
disease (Salgado et al., 2004).  Freeze-dried bone allograft material has been 
shown to reduce the antigenicity of the allograft (Quattlebaum et al., 1988) and 
demineralization of the bone prior to freeze-drying improves the osteogenicity of 
the allograft (Mellonig et al., 1981) as the decalcifying process exposes the bone 
morphogenetic proteins (Urist and Strates, 1971).  However, subsequent studies by 
Rummelhart et al. (1989) have shown no significant difference in periodontal 
bone-fill volume between freeze-dried bone allograft and demineralized freeze-
dried bone allograft.  Alloplastic materials include porous and non-porous 
hydroxyapaptite, tricalcium phosphate, polymers and glass-like materials.  
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Xenografts are transplants between two different species and once again, there is 
concern regarding the transfer of dangerous pathogens, although Ripamonti et al. 
(1996a; 2002a) have achieved successful periodontal regeneration in baboons 
using bovine insoluble collagenous bone matrix (ICBM) as delivery system for 
osteogenic growth factors.  
 
Root Surface Conditioning 
Root surface conditioning is the chemical treatment by agents such as citric acid, 
tetracycline hydrochloride or ethylenediaminetetraacetic acid (EDTA) whereby the 
root surface is rendered more conducive to the attachment of new periodontal 
tissue (Register and Burdick, 1975; 1976).  Adhesive systems such as fibrin-
fibronectin (Ripamonti et al., 1987) or enamel matrix derivatives (Sculean et al., 
2000) may be used in conjunction with root conditioning for superior cellular 
attachment which in turn would lead to regeneration of cementum, periodontal 
ligament and alveolar bone.  
   
Guided Tissue Regeneration (GTR) 
Guided tissue regeneration is a surgical technique in which a barrier membrane is 
placed between the instrumented root surface and the gingival flap, allowing 
selective cellular repopulation of a wound-healing site (Nyman, 1982b).  This 
technique allows periodontal ligament cells, which are slower to migrate and 
proliferate than gingival epithelium, to repopulate the root surface and to form new 
attachment (Melcher, 1976) followed by regeneration of cementum, periodontal 
ligament and alveolar bone.  Using this technique, Nyman and co-workers carried 
out extensive studies in animals and humans, and achieved new attachment on 
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previously diseased root surfaces (Nyman et al., 1982a; 1982b; Gottlow et al., 
1984; 1986; 1994; Karring et al., 1993; Lindhe et al., 1995).  
 
Growth Factors 
More recently, with the advent of protein isolation techniques, the application of 
osteoinductive growth factors has shown encouraging results in periodontal tissue 
regeneration (Giannobile, 1996).  Growth factors that have been positively 
associated with periodontal healing and regeneration include platelet derived 
growth factor (PDGF), insulin-like growth factor (IGF), fibroblast growth factor 
(FGF) and members of the transforming growth factor-beta superfamily, namely 
the bone morphogenetic proteins (BMPs) and the mammalian transforming growth 
factors -1, -2, and -3 (Graves and Cochran, 1994; Howell, et al., 1996; 
McCauley and Somerman, 1998; Cochran and Wozney, 1999).  BMPs have been 
used extensively by researchers to induce periodontal tissue regeneration in a 
variety of animal models (Ripamonti et al., 1994; Sigurdsson et al., 1995; Nevins 
et al., 1996; Ripamonti and Reddi, 1997; Kinoshita et al., 1997) as well as in 
human studies (Howell et al., 1997; Cochran et al., 2000) with varying degrees of 
success.  Ripamonti et al. (2006) proposed that BMPs possess a structure/activity 
profile with BMP-2 exhibiting mainly osteogenic properties while osteogenic 
protein-1 (OP-1), also known as BMP-7, was mainly cementogenic in its activities.  
In keeping with this theory, BMP-2 periodontal regeneration studies by Ripamonti 
et al., (2001) and Choi et al., (2002) have demonstrated enhanced alveolar bone 
formation but with limited cementum formation, whilst OP-1 periodontal 
regenerative studies have shown limited osteogenesis with a superior cementogenic 
deposition (Ripamonti et al., 1996a).   
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Very few periodontal regeneration studies using TGF-s have been performed. 
TGF-1 has been evaluated in dogs (Wikesjö et al., 1998; Tatakis et al., 2000) and 
sheep (Mohammed et al., 1998) but with disappointing results.  To date, very little 
is known about the regenerative capabilities of TGF-3 within the periodontal 
context.   
 
In this study, extra-oral autogenous bone was generated heterotopically in the 
rectus abdominis muscle in non-human primates of the genus Papio ursinus, using 
TGF-3 in Matrigel® as delivery system, or by using a synergistic combination of 
TGF-3 and OP-1 with an insoluble collagenous matrix (ICBM) as carrier.  The 
newly generated bone was transplanted to surgically created Class II maxillary and 
mandibular defects of the respective animals.  In addition, the tissue repair 
potential of TGF-3, applied directly to periodontal defects, was examined.   
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2. LITERATURE  REVIEW 
 
 
2.1 Tissue Engineering for Periodontal Tissue Regeneration 
 
Tissue engineering is based on soluble molecular signals, responding cells and 
biomaterial matrices for the repair and reconstruction of lost or diseased tissues 
(Langer and Vacanti, 1993; Reddi, 1994; Hubbell, 1995).  It can be defined as the 
application of biological, chemical and the principles of engineering to repair and 
regenerate living tissues, using cells, biological factors and biomaterials, alone or 
in combination (Laurencin et al., 1999).   
 
Periodontal tissue regeneration involves the restoration of both hard and soft tissue 
components and for this unique process to take place, several cell types need to 
interact in a coordinated and choreographed manner: endothelial cells for 
angiogenesis, fibroblasts for soft connective tissue, cementoblasts for 
cementogenesis and osteoblasts for osteogenesis (Pitaru et al., 1994; Bartold et al., 
2000).  The ideal treatment incorporates not only checking the destructive path of 
periodontal infection, but the replacement of lost periodontium.  True periodontal 
regeneration is the reconstitution of periodontal attachment apparatus, requiring the 
formation of new cementum, new alveolar bone, and new periodontal ligament 
with the insertion of functionally oriented connective tissue fibres (Sharpey’s 
fibres) in both the new cementum and the new alveolar bone (Lynch, 1992; 
Ripamonti and Reddi, 1994). 
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2.1.1  Periodontal Ligament 
 
The periodontal ligament (PDL) is the dense, highly organized connective tissue 
found between the root surface and the alveolar bone.  It forms a compact network 
that stretches between the cementum on the root surface and the surrounding 
alveolar bone and is firmly anchored by Sharpey’s fibres.  It plays a major role in 
the attachment of tooth to bone and consists mainly of fibroblast cells which play 
an important part in the development, function and regeneration of the tooth 
supporting apparatus (McCulloch, 1995; Beertsen et al., 1997).  Fibroblasts are 
able to remodel tissue by repopulating wounds and influencing the metabolism of 
other cell types (Häkkinen et al., 2000), culminating in new fibrous attachment 
(McCulloch, 1995).  Studies have shown that periodontal ligament cells, through 
unknown mechanisms, have the ability to differentiate into cementoblasts and 
osteoblasts, thereby forming cementum and alveolar bone (Roberts and Chase, 
1981; McCulloch, 1985; Cho and Garant, 1989; Lin, 1994).  The necessity of a 
functional PDL was emphasized in a study conducted by Löe and Waerhaug 
(1961) in which 58 teeth from dogs and monkeys were extracted and replanted.  
Thirteen teeth were replanted without PDL, 15 were air-dried for varying periods 
of time before being replanted and 30 were re-inserted immediately following 
extraction.  All 30 teeth belonging to the latter group became reattached 
successfully.  Those without PDL or with dried PDL showed limited areas of 
normal PDL and ankylosis occurred in both of these groups.  The investigators 
concluded that an intact PDL is vital when replanting teeth.  Younger (1893) had 
reached the same conclusion in 1892 when he read before the Second District 
Dental Society of Brooklyn, New York, his paper entitled “Some of the Latest 
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Phases in Implantation and Other Operations”.  At the time he had already 
experienced eight years of success in transplanting teeth.  He claimed that the 
“periodontal membrane” was critical to the success of the operation.  More 
recently, Ioannidou and Makris (2003) reported on a 12-year follow-up of an 
autogenous mandibular canine transplant.  At the time of surgery, the 11-year old 
patient had undergone autotransplantation of an impacted mandibular canine, 
situated in the anterior sextant, to its normal position in the mandible.  After 12 
years the tooth continued to remain stable with no sign of ankylosis.  Amongst the 
criteria listed for successful transplantation was the absence of trauma to the PDL. 
 
2.1.2      Cementum 
 
Cementum is one of the key tissues that support the tooth in the periodontium, the 
others being the periodontal ligament and alveolar bone.  It consists of a thin layer 
of calcified tissue covering the entire dentine surface and is located between the 
soft periodontal tissue and the root surface.  The main function of cementum is to 
give attachment to collagen fibres (Sharpey’s fibres) of the periodontal ligament 
(Berkovitz et al., 2002).  Attachment loss occurs when cementum is severely 
damaged during the inflammatory process of periodontitis.  Cementum is 
considered to be of pivotal importance in the initial process of periodontal 
development and regeneration (D’errico et al., 1997).  It may be cellular 
(containing cementocytes) or acellular.  Enamel matrix proteins are involved in the 
formation of acellular cementum and they have the potential to induce regeneration 
of the same type of cementum (Hammarstrom, 1997).  Studies carried out on the 
composition of cementum show that approximately 50% consists of 
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hydroxyapatite, the balance being collagen and non-collagenous proteins 
(Birkedal-Hansen et al., 1997).  Cementum is similar in composition to bone but at 
a microscopic level it becomes apparent that there are several distinct differences:  
cementum is avascular, has no innervation, does not undergo significant 
remodelling and has functions different to bone (D’errico et al., 1997).  At an ultra-
structural level, cementoblasts in vitro respond to growth factors and promote 
mineralization (Somerman et al., 1999; Zhao et al., 2004).  Protein extracts of 
cementum promote cell migration (Nishimura et al., 1989), attachment (McAllister 
et al., 1990; Somerman et al., 1991), proliferation (Miki et al., 1987) and protein 
synthesis (Somerman et al., 1987) of gingival fibroblasts and periodontal ligament 
fibroblasts.  These factors combined, play an important role in the formation and 
regeneration of gingival connective tissue (Miki et al., 1987; Knox and Aukhil, 
1988; McAllister et al., 1990). 
 
2.1.3  Alveolar Bone 
 
Alveolar bone is that part of the mandible or maxilla that supports the teeth.  The 
mandible and maxilla are formed by intramembranous ossification, which 
involves the initiation of bone by mesenchymal cells directly differentiating into 
osteoblasts with the subsequent synthesis of osteoid matrix and its mineralization.  
Most other skeletal components are formed primarily through endochondral 
ossification, which involves mesenchymal cells differentiating into chondroblasts 
to form cartilage, followed by vascular invasion and bone differentiation.   
Alveolar bone is dependent on the presence of teeth for its development and 
maintenance (Berkovitz et al., 2002).  Where teeth are absent, as in edentulous 
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patients, the alveolar bone is resorbed and the alveolar ridge becomes atrophic 
(Zernik et al., 1997; Berkovitz et al., 2002).  Alveolar bone protects the teeth and 
provides attachment for the collagenous fibres of the periodontal ligament.      
 
2.1.4 Biological Problems in Periodontal Tissue Regeneration 
 
There are several biological problems involved in periodontal wound healing:   
 
One wound margin consists of vascularized gingival connective tissue, whereas 
the other margin is avascular calcified root surface (Wikesjö et al., 1992).   
 
Initiation and promotion of osteogenesis from previously compromised tissue.   
 
Adhesion of the fibrin clot between the root surface and the gingival flap is 
crucial for the outcome of periodontal regeneration (Wikesjö et al., 1992; 
Wikesjö et al., 1995). 
 
Apical migration of epithelial cells, although this problem has been addressed 
by the utilization of a cell-occluding membrane (Nyman et al., 1982a). 
 
Type of defect: 3-wall intrabony defects heal more completely than 2-wall 
defects, and these in turn heal better than 1-wall defects (Listgarten and 
Rosenberg, 1979).  
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Reconstructing these diverse tissues of the periodontal attachment unit has inspired 
researchers to explore many avenues in their quest for complete periodontal 
regeneration.  However, to date, autogenous bone graft remains the gold standard 
for regenerating lost bone (Salgado et al., 2004).  Unfortunately, the limited 
amount of bone available, as well as donor site morbidity remains a major 
drawback for this technique.  Inducing bone in a soft tissue site and transplanting it 
to a bony site is a novel way of generating autogenous bone on demand thereby 
circumventing the problems of limited quantity and donor site morbidity.  A more 
abundant supply of autogenous bone, ready for transplantation, is certainly 
desirable and may become a viable alternative in the future.   In recent years, 
progress in regenerative medicine has made recombinant growth factors available 
as an alternative treatment for periodontal tissue regeneration.  These 
multifunctional biological mediators are able to regulate the proliferation and 
migration of various cell types and have been found to be beneficial within bony 
sites, including the periodontium (Anusaksathien and Giannobile, 2002). 
 
2.2 Growth Factors for Periodontal Tissue Regeneration 
 
 
Normal wound healing consists of three basic phases: inflammation, proliferation 
and remodelling and these occur in a predictable sequence of events reflecting a 
delicate balance of cellular and biochemical activity (Stadelman et al., 1998).  
Acute wounds release growth factors which stimulate cell activity up to three times 
that observed in fibroblast cells grown in serum-free culture (Bennet and Schultz, 
1993).  Chronic wounds, however, do not have the same reaction due to reduced 
levels of growth factors (Bennet and Schultz, 1993; Cooper et al., 1994).  Growth 
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factors are able to stimulate cell migration, proliferation, differentiation and matrix 
synthesis, which are the basic necessities for rapid tissue repair (Greenhalgh, 1996) 
and have therefore become a possible alternative treatment for tissue repair and 
regeneration.  Growth factors that have been identified as having a positive impact 
on periodontal healing and regeneration include: 
 
Platelet-derived growth factor (PDGF) 
Insulin-like growth factor (IGF) 
Fibroblast growth factor (FGF) 
Transforming growth factor-1, -2, and -3 (TGF-s) 
Bone morphogenetic proteins (BMPs) of the TGF- superfamily 
 
(Graves and Cochran, 1994; Howell, et al., 1996; McCauley and Somerman, 1998; 
Cochran and Wozney, 1999).   
 
For the purpose of this study only BMPs and TGF-s will be discussed further. 
 
2.2.1   Bone Morphogenetic Proteins in Periodontal Tissue Regeneration 
 
In species ranging from Drosophila melanogoster (fruit fly) to humans, bone 
morphogenetic proteins (BMPs) play a critical role as signaling molecules during 
embryogenesis (Sykaras and Opperman, 2003).  They are a unique group of 
morphogens within the transforming growth factor- superfamily, which play a 
key role in the induction, maintenance and repair of bone (Sykaras and Opperman, 
2003).  BMPs, originally isolated from extracellular matrix of bone, are capable of 
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inducing heterotopic cartilage and bone when implanted in muscle (Urist, 1965).  
Over the years, scores of BMPs have been identified (Celeste et al., 1990; Reddi, 
1997), with BMPs -2 through -7 known to induce bone (Wang et al., 1990).   
 
During tooth morphogenesis, the enamel knot, which is a transitory signaling 
centre, regulates tooth initiation and shape (Jernvall et al., 1994; Vaahtokari et al., 
1996; Åberg et al., 1997; Coin et al., 2000; Nakashima and Reddi, 2003).   BMPs -
2, -4, and -7 were localized by immunohistochemical techniques within the enamel 
knot, together with Sonic hedgehog (SHH) and fibroblast growth factor (FGF-4).  
BMPs -2, -4, -5 and -7 induce and form dentine and enamel, and BMP-3 is 
distributed in the dental follicle cells only, which give rise to cementoblasts and 
ultimately cementum (Åberg et al., 1997).   
 
Significant discoveries have been made in the use of BMPs to manipulate 
periodontal tissue repair and regeneration (Ripamonti et al., 1994; Ripamonti and 
Reddi, 1997; Giannobile et al., 1998; Ripamonti et al., 2002a).  Regenerative 
periodontal studies using different animal models and a variety BMPs and delivery 
systems have been very encouraging.  Sigurdsson et al., (1995) and Kinoshita et al. 
(1997) successfully achieved periodontal regeneration in dogs using recombinant 
human bone morphogenetic protein-2 (rhBMP-2) and a synthetic carrier.  New 
alveolar bone and cementum were noted.  Choi et al., (2002), however, also in a 
canine model and using rhBMP-2 in an absorbable collagen sponge carrier, 
achieved alveolar bone regeneration but poor cementum and periodontal ligament. 
These studies show consistently good results for the regeneration of alveolar bone 
using rhBMP-2 as do other studies using the same recombinant protein in goats 
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(Nevins et al., 1996), dogs (Toriumi et al., 1991), baboons (Ripamonti et al., 2001) 
and humans (Howell et al., 1997; Cochran et al., 2000).  Ripamonti et al. (2006) 
indicated that BMPs are pleiotropic in nature and possess a structure/activity 
profile with BMP-2 having mainly osteogenic capabilities while OP-1 (BMP-7) is 
predominantly cementogenic in its actions (Ripamonti et al., 2001; 2002a).  In 
support of this theory, many other studies using OP-1 (BMP-7) have demonstrated 
osteogenesis with a healthy cementogenic component in a variety of animal models 
(Giannobile et al., 1998; Ripamonti et al., 2002a; Jin et al., 2003).  Helder et al. 
(1998), in a study using BMP-7-deficient mice, demonstrated a functional 
redundancy when no qualitative differences in dental development were noted; 
only a slight retardation of 0.5 to 1.0 day in dental development, which was related 
to the general growth retardation of these animals.  It was therefore concluded that 
BMP-7 was not essential for tooth development.   
 
Clinical trials using rhBMP-2 in an absorbable collagen sponge carrier (Howell et 
al., 1997; Cochran et al., 2000) have yielded encouraging results with the protein 
and carrier being well tolerated locally and systemically.   Naturally-derived 
BMPs, then labelled as osteogenin, were the first BMPs to be used in a human 
periodontal study (Bowers et al., 1991).  When combined with demineralized 
freeze-dried bone allograft (DFDBA), and in a submerged environment, naturally-
derived BMPs significantly enhanced regeneration of new attachment apparatus 
and alveolar bone when compared to controls.  In the same study, naturally-derived 
BMPs plus collagen carrier showed no increase in bone or cementum.  Osteogenin, 
purified to homogeneity is known as BMP-3 (Luyten et al., 1989; Ripamonti et al., 
1992a).  Recently, in a rat fenestration defect study, BMP-6 was applied to an 
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absorbable collagen sponge and resulted in new bone and cementum formation in a 
dose dependent manner (Huang et al., 2005).  The authors claimed this to be the 
first study using BMP-6 in periodontal wound healing.  Lately, BMP-12 has 
become the focus of attention for periodontal regeneration studies.  In a canine 
study, Wikesjö et al. (2004) evaluated rhBMP-12 for periodontal regeneration, 
especially periodontal ligament formation.  Recombinant human BMP-12 and 
rhBMP-2 were implanted on absorbable collagen sponge in periodontal defects and 
the results were compared after 8 weeks.  More regenerated bone was observed in 
implants that had received rhBMP-2 but ankylosis was noted. Defects that had 
received rhBMP-12 showed less bone regeneration but exhibited a functionally 
oriented periodontal ligament, newly formed cementum and new alveolar bone.  
However, in a tooth replantation study using BMP-12, Sorensen et al. (2004) noted 
that a topical application of rhBMP-12 to teeth, which had been previously 
denuded of periodontal ligament, failed to re-establish new periodontal ligament.  
 
2.2.2 Transforming Growth Factor-β in Periodontal Tissue 
Regeneration 
 
Transforming growth factors-beta (TGF-s) are members of a large superfamily of 
growth factors.  They have the ability to promote or inhibit proliferation of many 
cell types in postnatal tissues and are modulators of cartilage and bone 
differentiation (Cox, 1995).  Nimni (1997) hypothesized that the term ‘growth 
factor’ was probably a misnomer for these polypeptides because they did not 
always encourage growth but acted rather as the modulators of cellular activities.  
Latent TGF-, activated by osteoclasts during bone resorption, stimulates 
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osteoblastic function and bone formation, suggesting that TGF-s play a key role 
in bone remodeling (Rose et al., 2004).  The TGF- family includes activins, 
inhibins, osteogenic proteins/bone morphogenetic proteins (OPs/BMPs) and four 
closely related TGF- isoforms, namely TGF-1, TGF-2 and TGF-3 which have 
been identified in mammals and TGF-5 detected in amphibians.   
 
TGF-s have been detected in alveolar bone, periodontal ligament and cementum 
at all stages of development and therefore play a significant role in the 
morphogenesis of tooth development (Heikinheimo, 1993; Thesleff et al., 1995; 
Gao et al., 1998).  Immunohistochemical localization of TGF-1, -2 and -3 in 
mouse embryo suggest multifunctional roles for these isoforms (Pelton et al., 
1991), especially during early tooth development (Ruch et al., 1995; Thesleff et 
al., 1995).   Cassidy et al. (1997) concluded that TGF- isoforms in dentine might 
provide a reservoir of growth factor that could be deployed in the processes leading 
to tissue repair.  A TGF- abrogation study on embryonic craniofacial 
morphogenesis (Chai et al., 1994) demonstrated that TGF-1 regulated 
chondrogenic cells, extracellular matrix and the development of Meckel’s 
cartilage, TGF-2 regulated tooth size, and TGF-3 regulated Meckel’s cartilage.  
TGF-3-deficiency has also been linked to the incidence of maxillary cleft palate 
(Chai et al., 1997; Slayton et al., 2003).     
 
Several in vitro studies have shown that TGF-s are able to stimulate fibroblast cell 
activity of the gingivae, promoting differentiation and proliferation (Anderson et 
al., 1998; Galetti et al., 2000; Marcopoulou et al., 2003).  Oates et al., (1993) 
noted that these activities were increased by TGF- in a dose-dependant manner.  
Bergue-Kirn et al. (1992) demonstrated that a TGF--like molecule present in 
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dentine could interact with other components to act as a modulator in the 
differentiation of odontoblasts.  The effects of TGF-s in periodontal repair in 
canine models has been unremarkable (Wikesjö et al., 1998; Tatakis et al., 2000).  
Mohammed et al. (1998) using TGF-1 in a periodontal regeneration study in 
sheep found that positive results were only evident after a membrane barrier was 
added.  The TGF-3 isoform is one of the three mammalian TGF- isoforms 
isolated from the TGF- superfamily.  It is considered to be far more potent as a 
regulator of functions associated with osteogenesis and angiogenesis than TGF-1 
or TGF-2 (Cox et al., 1994; Chien et al., 1999), and the main isoform found in 
canine periodontium (Coelho et al., 2004).  In addition, it is reported to be a 
powerful inducer of bone when implanted in heterotopic sites in non-human 
primates (Ripamonti et al., 2000).  To date, few studies have been carried out using 
TGF-3 for periodontal tissue regeneration.  
 
2.2.3  Synergy of Bone Morphogenetic Proteins and Transforming 
Growth Factor-β for Tissue Engineering  
 
Bliss (1939), as quoted by Greco et al. (1995), defined synergy as two agents 
acting in such a manner that neither one interferes with the other but each 
contributes to a common result.  Greco et al. (1996) also stated that synergy 
between two or more entities was usually considered to be a positive attribute of 
the combination and that the observed effect was greater than that which is the 
known effect of each agent working alone. 
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Ripamonti et al. (1997) induced large ossicles in extraskeletal sites in primate 
models when harnessing the synergistic action of rhTGF-1 combined with OP-1.  
The newly formed ossicles exhibited distinct morphological differences compared 
to those where rhOP-1 alone was used, showing large areas of endochondral 
development and extensive bone marrow formation.   The same results were noted 
by Duneas et al. (1998) when a binary application of rhOP-1 and platelet-derived 
porcine TGF-1 was used in calvarial sites in primates. Significant bone 
regeneration occurred when using the combination, whereas an application of 
TGF-1 alone did not induce any bone formation in calvarial sites.  Cho et al. 
(2002) examined the temporal patterns of mRNA expression for TGF-s during 
fracture healing in mouse tibias over a 28-day period and concluded that several 
members of the TGF- family are involved in fracture healing.  Each had a distinct 
temporal expression pattern and played a unique role in the healing process, 
although some TGF-s exhibited overlapping functions in promoting bone 
formation and differentiation.   
 
When taking into account the complexities of tissues being regenerated such as 
those found in the periodontium (Howell et al., 1996), synergistic activity may be 
needed for the optimal performance of morphogens/growth factors (Ripamonti et 
al., 2001).  Ripamonti et al. (1997) suggested that synergistic interaction might be 
a general activity in embryonic development and postnatal morphogenesis, an 
attribute that could be exploited in tissue engineering and postnatal regeneration.   
In an immunolocalization study by Thomadakis et al. (1999), the distribution of 
BMPs -2, -3, and -7 during root morphogenesis was examined in 12- to 18-day old 
mice. The complex expressions of BMPs during periodontal tissue morphogenesis 
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suggested that optimal therapeutic regeneration might entail the combined use of 
different BMPs. 
 
2.3 Skeletal Muscle for Tissue Engineering 
 
In 1970, Nogami and Urist reported that muscle-derived mesenchymal cells 
differentiated into cartilage and chondro-osseous tissue in cultures when foetal 
muscle tissue was placed on vessels made of demineralized rat bone matrix.  In a 
similar in vitro study conducted by Sampath et al. (1984), mesenchymal cells were 
transformed into chondrocytes using minced embryonic skeletal muscle cultured 
on hemicylinders of demineralized bone.  Using implants of minced skeletal 
muscle, Zacks and Sheff (1982), reported that nodules of cartilage and bone were 
induced in mouse limbs.  These nodules arose when regeneration of muscle from 
minced muscle was unsuccessful.  Subsequent studies have shown that skeletal 
muscle tissue contains cells which, when stimulated with a bone morphogenetic 
protein, are able to differentiate into osteoblasts (Lee et al., 2001;  Turgeman et al., 
2002;  Lu et al., 2003;  Corsi et al., 2004;  Sun et al., 2005) and that muscle-
derived cells are able to complete the differentiation pathway that leads to the 
formation of bone (Mastrogiacomo et al., 2005).  Unpublished data by Ripamonti 
et al. reported that minced skeletal muscle tissue when combined with a 
morphogen and added to a bony defect site, encouraged bone repair.   
 
In the present study, skeletal muscle, transplanted from the rectus abdominis 
muscle of the baboon, was added to rhTGF-3 with Matrigel® as carrier and 
implanted in periodontal defects. 
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2.4 Delivery Systems for Periodontal Tissue Regeneration  
   
One of the most critical aspects of wound repair by growth factor intervention is 
the use of an optimal delivery system (Rose et al., 2004).  In the event of an 
unsuitable carrier being chosen, the full potential of the osteogenic agent may not 
be achieved and doses above the therapeutic threshold may need to be employed 
(Li and Wozney, 2001). An experiment may be severely compromised if the 
delivery system is inadequate.  Kuboki et al. (1998a) demonstrated that the 
inductive properties of BMPs might depend on the type of carrier used.  In a 
periodontal regeneration experiment using cats and monkeys, a BMP cocktail was 
combined with either one or two layers of fibrous collagen membrane.  Those 
defects that had received BMP cocktail and one layer of fibrous collagen 
membrane showed only partial periodontal regeneration with evidence of 
ankylosis.  Defects that received BMP cocktail and two layers of fibrous collagen 
membrane showed alveolar bone, periodontal ligament and cementum with 
Sharpey’s fibres and no ankylosis.  In a canine periodontal regeneration study, 
Coelho et al., (2003) noted the consequences of using an inappropriate delivery 
system.  TGF-3, as the main isoform in intramembranous bone of the mandible 
(Coelho et al., 2004), showed minimal osteogenic regeneration when used in 
critical-sized defects with tricalcium phosphate (TCP) and polylactide acid (PLA) 
carriers.  The authors concluded that TGF-3, with its high capacity for stimulating 
mesenchymal cells at an angiogenic and osteogenic level, required a more 
efficacious delivery system. 
 
 
 22
The ideal delivery system should include the following criteria: 
 
It should serve as a three dimensional scaffold (Rose et al., 2004) which 
has surface properties that allow for cell adhesion, angiogenesis and nerve 
regeneration (Li and Wozney, 2001;  Rose et al., 2004;  Salgado et al., 
2004;  Holmes, 2002).  Studies in tissue engineering emphasize the 
importance of geometry of scaffolds in order to encourage cell attachment 
and differentiation (Ripamonti et al., 1992a; van Eeden and Ripamonti, 
1994; Magan and Ripamonti, 1996; Kuboki et al., 1998b; Ripamonti et al., 
1999; Jin et al., 2000; Ramoshebi et al., 2002; Holmes, 2002; Ripamonti, 
2004a).  Scaffold degradation rate should be in step with the growth rate of 
the newly formed tissue (Salgado et al., 2004; Hou et al., 2004), ensuring 
that new mechanical properties gradually replace those of the scaffold. 
 
Growth factors incorporated within the delivery system should not be 
compromised during the manufacturing process which may involve high 
temperatures or organic solvents being used (Rose et al., 2004).  The 
protein dose concentration should remain within a therapeutic range over a 
specific time period to allow for successful tissue regeneration (Nimni, 
1997).  Rapid diffusion of growth factors should be prevented and released 
in a time-controlled manner, stimulating and sustaining tissue regeneration 
(Li and Wozney, 2001; Rose et al., 2004; Hou et al., 2004).  In a rat study, 
Uludag et al. (2001) quantitated, by means of 125I-labeling, the levels of 
ectopically implanted rhBMPs and demonstrated that carriers with a higher 
retention ability elicited more bone formation.  In another rodent 
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experiment on the effects of carrier release kinetics, Talwar et al. (2001) 
compared fast and slow degrading gelatine carriers in rhBMP-2-induced 
periodontal healing.  Rapid protein release resulted in increased bone 
formation whilst slow protein release promoted a significant increase in 
cementum.   
      
The carrier should be biocompatible, lacking in cytotoxicity, causing only 
minimal inflammation and immune responses (Li and Wozney, 2001; Hou 
et al., 2004; Salgado et al., 2004; Holmes, 2002). 
 
Production, purification and processing should be easy and cost-effective 
(Li and Wozney, 2001; Holmes, 2002). 
 
The carrier should be user friendly, amenable to modification, and have an 
element of malleability in order to adapt to different defect sizes and 
contours (Li and Wozney, 2001; Holmes, 2002).  Mouldable materials are 
preferred as they have greater integration with surrounding tissue (Holmes, 
2002). 
 
Delivery systems may be naturally-derived or synthetic materials and include:   
 
Autogenous bone graft, which provides osteogenic cells and osteoinductive 
proteins required for bone regeneration (Rose and Oreffo, 2002).  It is bone taken 
from another part of the patient’s own body and as such is in limited supply due to 
donor site morbidity.  In a periodontal application it may be extra-oral, in which 
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case it is taken from the iliac crest, or intra-oral, which is usually obtained from the 
maxillary tuberosity or a healing extraction site (Simion and Fontana, 2004).  
  
Allograft bone is bone taken from a donor of the same species as the intended 
recipient and is subject to immune rejection and infections, or the transmission of 
pathogens from donor to host, which may occur after transplantation (Salgado et 
al., 2004).  Demineralized freeze-dried bone allograft (DFDBA) and freeze-dried 
bone allograft (FDBA) are examples of allograft bone.  Quattlebaum et al. (1988) 
however, claimed that the freeze-drying process of DFDBA significantly reduced 
its antigenicity making rejection less likely.  DFDBA has been used in human 
periodontal regeneration studies by Blank and Levy (1999) and Nevins et al. 
(2003).  
  
Xenografts are transplants between individuals of two different species.  These 
may carry dangerous viruses or pathogens such as spongiform encephalopathies, 
which are capable of being transmitted from animals to humans (Scott et al., 
1999).  Bovine insoluble collagenous bone matrix (ICBM) has been used 
successfully in periodontal defect sites in baboon experimental studies (Ripamonti 
et al., 1996a; Ripamonti et al., 2002a).   
 
Alloplastic materials are synthetic materials such as hydroxyapaptite, tricalcium 
phosphate, glass-like materials and biodegradable polymers such as polylactic acid 
(PLA) or polyglycolic acid (PGA).  Sigurdsson et al. (1995) used poly(D,L-
lactide-co-glycolide) (PLGA), which are synthetic bio-degradable particles, as 
carrier for rhBMP-2 in a periodontal regeneration study in dogs.   
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Preformed scaffolds such as absorbable collagen sponges (ACS) have been used 
extensively as carriers for rhBMP-2-induced periodontal regeneration in dogs 
(Choi et al., 2002), goats (Nevins et al., 1996) and humans (Howell et al., 1997; 
Cochran et al., 2000).  However, preformed scaffolds cannot be adapted with 
precision to conform to a bone defect site.   
   
Injectable systems that solidify in situ are particularly attractive and have the 
following advantages: 
 
They are surgically less invasive to the patient (Ritter-Jones and 
Messersmith, 2002; Hou et al., 2004). 
 
They can be used in areas that are difficult to access. 
 
The injected material is able to conform to the shape of the defect resulting 
in a three dimensional scaffold that is closely integrated with surrounding 
tissue (Ritter-Jones and Messersmith, 2002; Hou et al., 2004). 
 
Growth factors may be incorporated (Holmes, 2002; Ritter-Jones and 
Messersmith, 2002; Hou et al., 2004) and retained at an application site 
(Ululag et al., 2001). 
 
Solidification mechanisms for injectable scaffolds should occur under mild 
conditions so as to maintain high cell viability and molecular bioactivity as well as 
preventing any damage to surrounding tissue (Hou et al., 2004).  Solidification 
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methods include ceramic setting, thermally or photochemically triggered systems, 
and thermal gelation (Ritter-Jones and Messersmith, 2004; Hou et al., 2004).  
Matrigel® is an example of a thermally responsive biomatrix which is liquid at 4oC 
and gels at 37oC.  It is a soluble basement membrane extract of the Engelbreth-
Holm-Swarm tumour that gels rapidly to form a genuine reconstituted basement 
membrane (Kleinman et al., 1986).  Matrigel® matrix is also available as a growth 
factor-reduced product in which the level of a variety of growth factors, except 
TGF-, has been effectively reduced (Catalogue number 354230, BD Biosciences).  
Vukicevic et al. (1990) demonstrated vigorous growth and differentiation of bone 
cells on a reconstituted gel of basement membrane.  The cells formed clusters with 
interconnecting cytoplasmic projections similar to the canalicular network seen in 
bone.  However, the authors cautioned that the growth factors in Matrigel® were 
active and results should therefore be interpreted accordingly (Vukicevic et al., 
1992).  Maxian et al. (1998) examined the mitogenic behaviour of rat calvarial 
cells on various biomaterials coated with Matrigel®.  Biomaterials used were high 
and low crystallinity hydroxyapaptite, rough titanium and tissue culture 
polystyrene.  Alkaline phosphatase activity (APA) and cell growth were measured 
for Matrigel®-coated and uncoated surfaces.  APA was enhanced on the titanium 
surfaces and even more so on both types of hydroxyapaptite-coated surfaces in the 
presence of Matrigel®.    Ripamonti et al. (2002b) noted an increase in bone 
mineral density, as measured by dual photon x-ray absorptiometry, after injecting 
hOP-1 with Matrigel® as carrier into the lumbar vertebrae of oestrogen-deficient 
baboons.   
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The ensuing chapters will illustrate a method used for the regeneration of 
periodontal tissue by application of TGF-β3 alone, or in combination with skeletal 
muscle tissue, in an injectable, thermodynamic matrix.  The regenerative 
capabilities of growth factor-induced, extra-oral autogenous bone graft material 
will also be examined.   
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3. AIM  OF  STUDY 
 
 
The aims for this study were as follows: 
 
1. To determine whether rhTGF-3, or rhTGF-3 plus muscle tissue from the 
rectus abdominis, delivered by Matrigel® as carrier, will induce periodontal 
tissue regeneration in bilateral, surgically created periodontal defects in the 
first and second molars of both the mandible and the maxilla of the adult 
baboon (Papio ursinus). 
 
2. To determine whether induced autogenous bone, generated heterotopically 
in the rectus abdominis muscle, using TGF-3 in Matrigel® carrier, or using 
a synergistic combination of TGF-3 and osteogenic protein-1 (OP-1) in 
Matrigel® carrier, are viable devices for transplantation to induce healing in 
bilateral, surgically-created periodontal defects in the first and second 
molars of both the mandible and the maxilla of the adult baboon (Papio 
ursinus). 
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4.  MATERIALS  AND  METHODS 
 
 
4.1  Animals 
 
Four clinically healthy adult baboons (Papio ursinus) with an average body mass 
of 21,5 kg were selected from the non-human primate colony of the University of 
the Witwatersrand, Johannesburg.  The animals were caged individually in rooms 
kept under slight negative pressure (-25 kPa) with controlled ventilation (18 
filtered air changes per hour), temperature (22 ± 2° C), humidity (40 ± 10%) and 
photoperiod (lights on 06h00 to 18h00). The animals were fed a diet of basic 
proteins, carbohydrates, dietary fibre, fats, calcium, iron, phosphates and vitamins 
(riboflavin, nicotinic acid and thiamine). 
 
4.2   Implant Materials 
 
The soluble molecular signals to induce heterotopic autogenous bone were 
transforming growth factor-beta 3 (TGF-3) and osteogenic protein-1 (OP-1).  
TGF-3 was used either alone or in combination with OP-1 in either Matrigel® 
matrix or insoluble collagenous bone matrix (ICBM) as carrier.   
 
The periodontal implants consisted of TGF-3 alone, TGF-3 together with 
minced muscle tissue, and the heterotopically induced autogenous bone material 
harvested from the rectus abdominis muscle. 
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4.2.1 Growth Factors 
 
4.2.1.1 rhTGF-3 (Novartis, Basel, Switzerland) 
 
The dilutions for rhTGF-3 were made as described in Appendix 1.  Briefly, a 
stock solution was made by re-suspending 800 µg rhTGF-3 in 2000 µl of 5 mM 
HCl.  This solution was aliquotted into amounts of 125 µl stock solution for the 2.5 
µg rhTGF-3 and 1.5 µg rhTGF-3 doses and 1875 µl stock solution for the 75 µg 
rhTGF-3 dose.  A constant volume of 200 µl per dose was used for both 
heterotopic and periodontal implants.   
 
4.2.1.2 rhOP-1 (Stryker Biotech, U.S.A.).  
 
As shown in Appendix 2, the required dose of 25 µg rhOP-1 was made from an 
available stock solution.   
 
4.2.2 Muscle Tissue 
 
Freshly harvested muscle tissue taken from the rectus abdominis during the second 
surgical procedure (Phase 2) was used in this study.  The muscle was minced with 
scalpel blades and added to rhTGF-β3 and Matrigel® at the time of surgical 
implantation (Phase 2). 
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4.2.3  Delivery System 
 
4.2.3.1 Growth Factor-Reduced (GFR) Matrigel® Matrix (BD Biosciences, 
catalogue number 354230).   
 
Matrigel® matrix is a soluble basement membrane extract of the Engelbreth-Holm-
Swarm tumour that is liquid at 4oC and gels rapidly at 37oC to form a genuine 
reconstituted basement membrane (Kleinman et al., 1986). 
 
4.2.3.2    Insoluble Collagenous Bone Matrix (ICBM)  
 
ICBM was prepared as shown in Appendix 3.   Briefly, baboon cortical bone was 
dehydrated with alcohol, crushed and demineralized with hydrochloric acid after 
which it was neutralized and treated with guanidinium hydrochloric acid 
containing protease inhibitors (Sampath and Reddi, 1981; Ripamonti et al., 1992b).   
 
4.3  Preparation of Implants 
 
4.3.1 Matrigel®-Based Implants    
   
As per manufacturer’s specifications, to maintain a gelled consistency, a Matrigel® 
dilution not exceeding 1:3 was used.  Appendix 4 shows the method used for 
making the Matrigel®-based implants.  In short, a volume of 200 µl growth factor 
solution was added to 400 µl Matrigel® delivery system resulting in a final volume 
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of 600 µl of implant device. Prepared devices were stored in the cold until 
implantation.    
 
4.3.2  ICBM-Based Implants 
 
As shown in Appendix 5, rhTGF-3 and rhOP-1 were combined with ICBM to 
allow for protein precipitation into the ICBM.  Chondroitin sulphate and baboon 
type I collagen were added followed by washing and centrifuging in pre-chilled 
ethanol.  The pellets were drained by briefly inverting the tubes on paper towel 
after which they were lyophilized overnight. 
 
4.4  Surgery on Baboons 
 
Surgery was performed in three phases.  During the first phase growth factors were 
implanted heterotopically in the rectus abdominis muscle of each animal and 
periodontal defects were prepared.  After 40 days (Phase 2), autogenous bone in 
the form of ossicles was harvested from each animal and these were fragmented 
and implanted in periodontal defect sites.  At the same time, selected periodontal 
defects were implanted with rhTGF-3 and rhTGF-3 plus muscle tissue in 
Matrigel® carrier. Control defects were filled with Matrigel® only.  The defects 
were allowed to heal for 60 days after which the animals were euthanased (Phase 
3).     
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4.4.1 Phase 1:  Heterotopic Implantation of Molecular Soluble Signals 
for the Induction of Autogenous Bone and Preparation of 
Periodontal Defects.   
 
4.4.1.1 Heterotopic Surgery 
 
Day 0.  The animals were fasted before surgery and immobilized with an 
intramuscular injection of ketamine hydrochloride (10 mg per kilogram of body 
weight) and anesthetized intravenously using thiopentone sodium (30 mg per 
kilogram of body weight).  Anaesthesia was maintained with halothane vapour in 
100 per cent oxygen following rhinotracheal intubation.  The ventral aspect of the 
animal was exposed, shaved, rendered aseptic with Hibitane and the area of interest 
surrounded by sterile drapes.  Five (for Animals 1 and 3) or four (for Animals 2 
and 4) ventral intramuscular pouches (Figure 4.1) were made by sharp and blunt 
dissection as follows:  Using sterile operative techniques, longitudinal incisions, 
measuring 15 - 20 mm, were made bilaterally in the rectus abdominis muscle of 
each of the four baboons.  The following materials were implanted: 
Matrigel® carrier together with 75 µg rhTGF-β3 (Figure 4.2), 
Matrigel® carrier together with 2.5 µg rhTGF-β3 and 25 µg rhOP-1 (Figure 
4.2),  
Matrigel® carrier together with 1.5 µg rhTGF-β3 and 25 µg rhOP-1 (Figure 
4.2),  
ICBM carrier together with 2.5 µg rhTGF-β3 and 25 µg rhOP-1 (Figure 
4.3),  
ICBM carrier with 1.5 µg rhTGF-β3 and 25 µg rhOP-1 (Figure 4.3).  
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Matrigel®-based implants were allowed to stand at room temperature for 15 – 30 
minutes before use, and applied using sterile 1 ml syringes (Figure 4.2). 
Figures 4.4 and 4.5 show the surgical implant design used for each animal.  The 
design for Animals 1 and 3 were alike and the design for Animals 2 and 4 were 
alike.  The incisions were closed in layers using resorbable sutures.   
 
 
 
 
 
 
 
 
Figure 4.1.  Heterotopic implant site in the rectus abdominis muscle.  Green arrow 
indicates pouch made to receive implant. 
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Figure 4.2.  Application of Matrigel®-based implant in the rectus abdominis 
muscle. 
 
 
 
 
 
 
 
 
Figure 4.3 Application of ICBM-based implant in the rectus abdominis muscle. 
 36
 
Figure 4.4  Animals 1 and 3:  Surgical implant design for heterotopic implants. 
 
 
 
 
Figure 4.5  Animals 2 and 4:  Surgical implant design for heterotopic implants. 
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4.4.1.2     Periodontal Surgery 
 
Day 0.  Full thickness mucoperiosteal flaps were raised to expose the alveolar 
bone.  A total of eight Class II furcation defects, measuring 6-8 mm in height and 
with a buccolingual depth 10-12 mm, were made bilaterally in the first and second 
molars of both the mandible and maxilla of each animal (Ripamonti et al., 1994; 
1996a).  Class II furcation defects exceed the horizontal periodontal tissue loss 
limit of 3 mm as seen in Class I, but do not exhibit the horizontal “through and 
through” destruction of periodontal tissue of Class III furcation defects (Hamp et 
al., 1975.)  The exposed root surfaces were denuded of periodontal ligament fibres 
and cementum.  The flaps were realigned and sutured using resorbable sutures.  
Postoperative pain was controlled by buprenorphine hydrochloride administered by 
intramuscular injection.    
  
4.4.2  Phase 2:  Harvesting of Heterotopically Induced Autogenous Bone 
and Implantation of Periodontal Defects. 
 
4.4.2.1     Heterotopic Surgery 
 
Day 40.  On day 40 it was noted that several of the ossicles had been resorbed.   
The presence of these ossicles had been previously determined by palpation of the 
abdomen.  Of the eighteen implants only seven ossicles were harvested. Tables 4.1, 
4.2, 4.3 and 4.4 show the fate of the heterotopic implants after 40 days.  Table 4.5 
gives a summary of the remaining ossicles as well as those which were lost to the 
resorption process.  It should be noted at this point that only Matrigel®-based 
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implants were meant to be transplanted to periodontal sites and that the ICBM-
based implants were for laboratory interest only.  However, in light of the fact that 
none of the low-dose Matrigel®-based implants survived the 40 day implant period, 
an ad hoc decision was made to use two of the ICBM-based ossicles for 
transplantation to the periodontium (Animals 2 and 4).  All surviving ossicles were 
surgically removed from the anaesthetized animals and those earmarked for 
transplantation were fragmented with a scalpel and placed on ice to await 
transplantation to periodontal defect sites (Figures 4.6 and 4.7).  In an effort to 
retain a balanced study (i.e. Animals 1 and 3 alike and Animals 2 and 4 alike), it 
was decided that Animals 1 and 3 receive the 75 µg/Matrigel® ossicles and 
Animals 2 and 4 receive the 2.5 µg rhTGF-β3/25 µg rhOP-1/ICBM ossicles for 
transplantation to the periodontium.  Ossicles were assessed only as having 
sufficient material for transplantation and were therefore not weighed, measured or 
radiographed during surgery.  Any ossicle or portion thereof that was not used for 
transplantation to a periodontal defect site was placed in 10% phosphate buffered 
formalin in preparation for histological analysis. 
 
 
Table 4.1  Animal 1:  Heterotopic implant doses and fate of implants after forty  
days. 
 
Implant 
Site No. 
Type of implant Fate of implant 
1 75 µg rhTGF-β3 in Matrigel® Transplanted to left and right 
maxillary defects 
2 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel®   Resorbed 
3 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
4 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Resorbed 
5 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Harvested for histology 
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Table 4.2  Animal 2:  Heterotopic implant doses and fate of implants after forty 
days. 
Implant 
Site No. 
Type of implant Fate of implant 
1 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
2 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
3 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Transplanted to left maxillary 
defects 
4 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Resorbed 
 
 
 
Table 4.3  Animal 3:  Heterotopic implant doses and fate of implants after forty 
days. 
Implant 
Site No. 
Type of implant Fate of implant 
1 75 µg rhTGF-β3 in Matrigel® Transplanted to left and right 
maxillary defects 
2 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
3 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
4 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Harvested for histology 
5 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Harvested for histology 
 
 
 
Table 4.4  Animal 4:  Heterotopic implant doses and fate of implants after forty 
days. 
Implant 
Site No. 
Type of implant Fate of implant 
1 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
2 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in Matrigel® Resorbed 
3 2.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Transplanted to right 
maxillary defects 
4 1.5 µg rhTGF-β3 plus 25 µg rhOP-1 in ICBM Resorbed 
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Table 4.5  Summary of fate of heterotopic implants.   
Both 75 µg rhTGF-β3 in Matrigel® implants (Animals 1 and 3) were harvested.  
All 2.5 µg rhTGF-β3/Matrigel® and 1.5 µg rhTGF-β3/Matrigel® implants were 
resorbed.  Three 2.5 µg rhTGF-β3/25 µg rhOP-1/ICBM implants (Animals 2, 3 
and 4) and two 1.5 µg rhTGF-β3/25 µg rhOP-1/ICBM implants (Animals 1 and 3) 
were harvested. 
 
 
Doses for Heterotopic Implants 
 
 
 
 
Animal 
75µg 
rhTGF-β3/ 
Matrigel® 
2.5 µg 
 rhTGF-β3/  
25 µg rhOP-1/ 
Matrigel®  
1.5 µg  
rhTGF-β3/  
25 µg rhOP-1/ 
Matrigel®  
2.5 µg  
rhTGF-β3/  
25 µg rhOP-1/ 
ICBM  
1.5 µg  
rhTGF-β3/ 
 25 µg rhOP-1/ 
ICBM 
 
 1 
 
+ 
 
_ 
 
_ 
 
_ 
 
+ 
 
 2 
 
 
Not 
implanted 
 
_ 
 
_ 
 
+ 
 
_ 
 
 3 
 
+ 
 
 
_ 
 
_ 
 
+ 
 
+ 
 
 4 
 
Not 
implanted 
 
_ 
 
 
 _ 
 
+ 
 
_ 
     
Key:      ( + )  =  harvested ossicle;              (     )  =  resorbed ossicle. 
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Figure 4.6.  Harvested ossicle of autogenous bone from the rectus abdominis 
muscle.  The yellow arrow indicates muscle fascia;  the green arrow indicates 
underlying muscle tissue containing endochondral bone. 
 
 
 
 
 
Figure 4.7.  Fragmented ossicle of autogenous bone from the rectus abdominis 
muscle for transplantation. 
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4.4.2.2 Periodontal Surgery 
 
Day 40.  The mucoperiosteal flaps were raised and the granulation tissue resulting 
from the creation of the critical-sized defects was removed by curetting and 
planing the root surfaces (Figure 4.8).  A small bur was used to make a horizontal 
groove on each root to indicate the base of the defect, that is, the residual bony 
housing.  The furcation defects were ‘packed’ (Figure 4.9) with one of the 
following:  
Matrigel® carrier alone as control  
Matrigel® carrier and rhTGF-β3  
Matrigel® carrier, rhTGF-β3, and minced muscle tissue 
Heterotopically induced autogenous bone, harvested from the rectus abdominis 
muscle, minced with a scalpel 
 
Figures 4.10, 4.11 and 4.12 and Tables 4.6, 4.7 and 4.8 show the implantation sites 
and types of implants that were implanted or transplanted for Animals 1 to 4.  
 
The mucoperiosteal flaps were reattached using resorbable sutures.   
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Figure 4.8  Class II furcation defects in first and second maxillary molars prior to 
implanting with autogenous bone. 
 
 
 
 
 
 
 
 
Figure 4.9  First and second maxillary molars after implanting with fragmented 
autogenous bone. 
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Figure 4.10  Animals 1 and 3:  Surgical implant design for periodontal implants. 
 
 
 
 
Table 4.6  Animals 1 and 3:  Location of periodontal implants and doses of 
implants. 
 
Location of implant Type of implant 
Left maxilla, 1st and 2nd molars 75 µg rhTGF-β3/Matrigel® ossicle 
Right maxilla, 1st and 2nd molars 75 µg rhTGF-β3/Matrigel® ossicle 
Left mandible, 1st and 2nd molars 75 µg rhTGF-β3, Matrigel® plus muscle 
tissue 
Right mandible, 1st and 2nd molars 75 µg rhTGF-β3, Matrigel® plus muscle 
tissue  
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Figure 4.11  Animal 2:  Surgical implant design for periodontal implants. 
 
 
 
 
 
Table 4.7  Animal 2:  Location of periodontal implants and doses of implants. 
Location of implant Type of implant 
Left maxilla, 1st and 2nd molars 2.5 µg rhTGF-β3/25 µg rhOP-1/ICBM 
ossicle 
Right maxilla, 1st and 2nd molars Matrigel® solo (control) 
Left mandible, 1st and 2nd molars Matrigel® solo (control) 
Right mandible, 1st and 2nd molars 75 µg rhTGF-β3 and Matrigel® 
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Figure 4.12  Animal 4:  Surgical implant design for periodontal implants. 
 
 
 
 
 
Table 4.8  Animal 4:  Location of periodontal implants and doses of implants. 
Location of implant Type of implant 
Left maxilla, 1st and 2nd molars Matrigel® solo (control) 
Right maxilla, 1st and 2nd molars 2.5 µg rhTGF-β3/25 µg rhOP-1/ICBM 
ossicle 
Left mandible, 1st and 2nd molars Matrigel® solo (control) 
Right mandible, 1st and 2nd molars 75 µg rhTGF-β3 and Matrigel® 
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4.4.3  Phase 3:  Euthanasia and Harvest of Periodontal Tissue 
 
Day 100.  Sixty days after implantation of periodontal defects, anaesthetized 
animals were euthanased using an overdose of sodium pentobarbitone.  Bilateral 
carotid saline perfusion, using 0.9 % saline, followed by 10 % formaldehyde 
perfusion was performed.  The first and second maxillary and the mandibular 
molars of each animal, together with surrounding bone and soft tissue, were 
harvested en bloc and fixed in 10 % phosphate buffered formalin.  Each resected 
specimen block measured approximately 25 mm x 20 mm. 
  
4.5  Photography and Radiography 
 
Photographs were taken during all phases of surgery using a Nikon 35 mm camera 
using a 200 mm medical Nikkor focal lens. 
 
Intra-oral periapical radiographs, with an exposure time of 0.4 minutes, were taken 
during Phases 2 and 3 of surgery using a Philips Oralix 50.                                                                                                                                                                     
 
4.6    Tissue Processing of Specimens. 
 
As described in Appendix 6, the periodontal and heterotopic specimens were 
processed by dehydrating through ascending grades of ethanol, cleared in toluene, 
and infiltrated and embedded in K-Plast resin (MEDIS-Weber) in preparation for 
the cutting of undecalcified sections.  The polymerized blocks of periodontal tissue 
were trimmed on a Leica SM2500E heavy-duty microtome using 16 cm D-profile 
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tungsten carbide knives until the defect indication notches made during surgery 
became visible.   After locating the notches, the sections cut at six microns were 
labelled level one through level one hundred.  The polymerized blocks of 
heterotopic specimens were similarly trimmed on the Leica SM2500E heavy-duty 
microtome using 16 cm D-profile tungsten carbide knives until the entire surface 
area of the specimen was exposed, after which six micron sections were cut and 
labelled level one through level thirty.  All sections were stained free-floating 
using a modified Goldner’s trichrome staining method for undecalcified sections as 
described in Appendix 7.  Briefly, the nuclei were stained with stable iron 
haematoxylin, followed by Ponceau Fuchsin with Orange G differentiation for 
osteoid.  Mineralised bone was stained with methyl blue.  Sections were examined 
microscopically, using an Olympus Provis AX70 Research Microscope, for 
evidence of periodontal tissue regeneration.    
 
4.7   Histomorphometric analysis 
 
4.7.1 Heterotopically Induced Autogenous Bone 
 
Using the Olympus Provis AX70 microscope at 4x magnification and a 100 lattice 
point Zeiss Integration Platte II, the fractional volume of bone (i.e. mineralized 
bone plus osteoid), cartilage and carrier matrix was measured by means of the 
point counting technique (Parfitt, 1983).  Histological sections of the Matrigel®-
based and ICBM-based autogenous bone ossicles at levels 1 and 30 were selected 
for histometric analysis.  By superimposing the graticule over two sources (Parfitt 
et al., 1987), two hundred points per slide were measured i.e. four hundred points 
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per ossicle.  The calculations were expressed in mean percentage values.  Using 
GraphPad Prism computer software for statistical analyses, the mean values, 
standard deviation and standard error were calculated and bar graphs were plotted. 
P-value was calculated by one-way analysis of variance (ANOVA).  
  
4.7.2 Periodontal Defects 
 
Histological sections of the periodontal defects at levels 1, 50 and 100 were 
selected for histomorphometric analysis.   
 
Area (%) 
Using the Olympus Provis AX70 microscope at 2x magnification and analySIS® 
Imager imaging software system with CC12 digital camera (Wirsam Scientific and 
Precision Equipment, South Africa), the area of newly-formed bone was measured 
from the apical border of the notch to the coronal area of the furcation and 
compared to total defect size.  Measurements were expressed as a percentage (%) 
of the total defect size.   
 
Linear Measurements (mm) 
The height of new alveolar bone in relation to total defect height at the medial and 
distal aspects of each furcation defect was also measured.  Measurements of new 
cementum were also taken.  Measurements were expressed in millimetres (mm). 
 
Volume (%) 
Using the Olympus Provis AX70 microscope at 4x magnification and a 100 lattice 
point Zeiss Integration Platte II, the fractional volume of mineralized bone and 
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osteoid was calculated by means of the point counting technique (Parfitt, 1983) on 
histological sections of periodontal defects at levels 1, 50 and 100.  By 
superimposing the graticule over two sources, namely apical and coronal areas 
(Parfitt et al., 1987), two hundred points per slide were measured i.e. six hundred 
points per furcation defect.  The calculations were expressed percentage. 
 
Using GraphPad Prism computer software for statistical analyses, mean value and 
standard error of the mean were calculated and bar graphs were plotted.  P-value 
was calculated by one-way analysis of variance (ANOVA).  The following criteria 
were assessed: 
Performance of all five variables in periodontal defect sites: 
Matrigel® solo (control),    
75 µg rhTGF-β3 and Matrigel®,  
75 µg rhTGF-β3, Matrigel® and muscle tissue, 
Matrigel®-based autogenous bone, 
ICBM-based autogenous bone. 
Area of newly regenerated alveolar bone compared to total defect area. 
Height of newly regenerated alveolar bone and cementum compared to 
defect height. 
Regeneration of alveolar bone by individual animals, with special emphasis 
on the regenerative capabilities of Animals 2 and 4.   
Regeneration of alveolar bone in mandibular defects compared to 
regeneration of alveolar bone in maxillary defects. 
Regeneration of alveolar bone in first molar compared to regeneration of 
alveolar bone in second molar. 
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5. RESULTS 
 
Results of this study have been reported in two parts.  The first section examines 
the portions of heterotopically induced autogenous bone that remained after 
transplantation to periodontal sites as well as the ossicles that were not used for 
transplantation.  Photomicrographs of the histological findings are shown together 
with data tables and histograms to illustrate osteogenic viability.  Part two of this 
chapter gives the results of the treated periodontal defects after the sixty day 
healing period and includes photomicrographs, data tables and histograms. 
 
 
 
 
5.1    Heterotopic Implants for Autogenous Bone  
 
5.1.1 Histological Observations 
 
5.1.1.1 75 µg rhTGF-3/Matrigel®-Induced Autogenous Bone 
 
The remnants of two rhTGF-3/Matrigel® autogenous bone ossicles were 
processed for histological analysis, the bulk of each ossicles having been 
transplanted to a periodontal defect site.  The histological sections showed multiple 
areas of osteogenesis (Figures 5.1 and 5.2) and chondrogenesis (Figure 5.2).  
Residual Matrigel® carrier was not seen.  
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Figure 5.1  Autogenous bone:  Photomicrograph of a 75 µg rhTGF-3/Matrigel®-
induced ossicle showing mineralized bone (blue areas), 1.25x magnification.  
Modified Goldner’s stain. 
 
 
 
 
 
Figure 5.2  Autogenous bone:  Photomicrograph of a 75 µg rhTGF-3/Matrigel®-
induced ossicle showing bone and cartilage within autogenous bone graft material, 
20x magnification.  Modified Goldner’s stain. 
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5.1.1.2 2.5 µg rhTGF-3/25 µg rhOP-1/ICBM-Induced Autogenous Bone 
 
The transplant remnants of two 2.5µg rhTGF-3/25 µg rhOP-1/ICBM autogenous 
bone ossicles, plus one ossicle that had not been transplanted were processed for 
histological assessment.  The histology sections (Figure 5.3) showed multiple areas 
of osteogenesis with residual ICBM.  The remnants of the two transplanted ossicles 
(from Animals 2 and 4) did not appear to have a cartilaginous component (Table 
5.4) but the ossicle harvested from Animal 3 showed a healthy chondrogenic 
element (Table 5.5).  The chondrogenic cells appeared to be restricted to the 
periphery of the ossicles.  The ossicle harvested from Animal 4 had the least 
osteogenic material and the most residual carrier matrix (Figure 5.4 and Table 5.4)  
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A        B 
 
Figure 5.3  Autogenous bone:  Photomicrograph of a 2.5 µg rhTGF-3/25 µg  
rhOP-1/ICMB-induced ossicle showing bone content (blue areas), (A) 1.25x 
magnification;  (B) 4x magnification.  Modified Goldner’s stain. 
 
 
 
 
 
 
 
 
 
 
Figure 5.4  Autogenous bone:  Photomicrograph of a 2.5 µg rhTGF-3/25 µg  
rhOP-1/ICMB-induced ossicle harvested from Animal 4 showing sparse 
distribution of bone (yellow arrows) and abundant residual carrier (white arrows) 
within autogenous bone graft material, 4x magnification.  Modified Goldner’s 
stain. 
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5.1.1.3 1.5 µg rhTGF-3/25 µg rhOP-1/ICBM-Induced Autogenous Bone 
 
These ossicles were not used for transplantation to a periodontal site but were 
processed for histological analysis.  Histology sections (not shown) revealed an 
abundance of osteogenic material, very similar to the rhTGF-3/Matrigel® 
autogenous bone ossicles, but with less chondrogenesis (Figure 5.5, Table 5.1 and 
Table 5.5).  A small amount of residual ICBM carrier was noted. 
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5.1.2  Histomorphometric Analysis 
 
Figure 5.5 and Table 5.1 show the distribution of mineralized bone, osteoid, 
cartilage and carrier matrix within the harvested induced autogenous bone ossicles.  
Values, expressed as a percentage of the mean, show that the 75 µg rhTGF-3/ 
Matrigel® and 1.5µg rhTGF-3/25 µg rhOP-1/ICBM ossicles had similar bone 
volume (40.9% and 39.7%, respectively) (Table 5.1) with different cartilage 
content (8.8% and 2.7%, respectively).  The 2.5µg rhTGF-3/25 µg rhOP-1/ ICBM 
ossicles, although with similar bone volume (30.1%), had an amount of 12.8% 
residual carrier matrix when compared to the 75 µg rhTGF-3/Matrigel® and 1.5µg 
rhTGF-3/25µg rhOP-1/ICBM ossicles (0% and 2.6%, respectively) (Table 5.1).  
There were no significant differences between the three types of ossicles (p >0.05) 
as shown by Bonferroni’s Multiple Comparison Test (Table 5.2).   
 
Table 5.3 shows the bone volume of the 75µgTGF-3/Matrigel® ossicles 
transplanted to periodontal defects.   The ossicles were similar in bone volume 
(43.7% and 38.2%) and neither contained residual carrier matrix.  
 
Table 5.4 shows the bone volume of the 2.5µgTGF-3/25µg rhOP-1/ICBM 
ossicles transplanted to periodontal defects.   The ossicle from Animal 4 consisted 
of less bone volume and contained more carrier matrix (Figure 5.4 and Table 5.4) 
than the ossicle harvest from Animal 2 (Figure 5.3 and Table 5.3).   
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Table 5.5 gives the bone volume of the three ossicles that were not transplanted to 
a periodontal site.  It was noted that the ossicle with the highest bone content 
(46.7%) was that of a 1.5µgTGF-3/25 µg rhOP-1/ICBM ossicle. 
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Induced Autogenous Bone Ossicles 
 
Key 
AB(75µg/Mat)  
  
Autogenous bone ossicles induced by 75 µg TGF 3/Matrigel®  
AB(2.5µg/ICBM)
   
Autogenous bone ossicles induced by 2.5 µg rhTGF 3/25 µg rhOP-1/ 
ICBM  
AB(1.5µg/ICBM) Autogenous bone ossicles induced by 1.5 µg rhTGF 3/25 µg rhOP-1/ 
ICBM  
 
Figure 5.5  Distribution of mineralized bone, osteoid, cartilage and carrier matrix 
within the harvested induced ossicles.  Values are expressed in percentage.  
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Table 5.1  Volume fraction (%) of  bone (mineralized bone plus osteoid), cartilage 
and residual matrix in the seven ossicles of induced bone harvested from the rectus 
abdominis of the baboons.  Values are expressed as mean and standard error of the 
mean (SEM);  n indicates the number of ossicles harvested for each implant 
variable.  
 
 
75µgTGF-3/Matrigel 
Ossicle 
 
2.5µgTGF-3/ 
25µg rhOP-1/ICBM 
Ossicle 
 
1.5µgTGF-3/ 
25µg rhOP-1/ICBM 
Ossicle 
 
 
 
 Mean SEM n Mean SEM n Mean SEM n 
 
Bone 
 
40.9 
 
± 2.7 
 
2 
 
30.1 
 
± 4.5 
 
3 
 
39.7 
 
± 7.0 
 
2 
 
Mineralized 
Bone 
 
26.1 
 
± 1.9 
 
2 
 
20.9 
 
± 3.8 
 
3 
 
25.1 
 
± 6.6 
 
2 
 
Osteoid 
 
14.8 
 
± 0.8 
 
2 
 
9.1 
 
± 1.8 
 
3 
 
14.6 
 
± 0.4 
 
2 
 
Cartilage 
 
8.8 
 
± 2.1 
 
2 
 
1.6 
 
± 1.6 
 
3 
 
2.7 
 
± 2.7 
 
2 
 
Matrix 
 
0.0 
 
0.0 
 
2 
 
12.8 
 
± 8.0 
 
3 
 
2.6 
 
± 2.6 
 
2 
 
 
 
 
 
Table 5.2  Bonferroni’s Multiple Comparison Test comparing  
75µgTGF-3/Matrigel® ossicle (Column A),   
2.5 µg TGF-3/25 µg rhOP-1/ICBM ossicle (Column B) and  
1.5 µg TGF-3/25 µg rhOP-1/ICBM ossicle (Column C).   
There is no significant difference between the three types of ossicles (p > 0.05).  
 
 
Bonferroni's Multiple 
Comparison Test 
 
 
Mean Diff. 
 
t 
 
p value 
 
95% CI of diff 
 Column A vs Column B 
 
3.207 0.3522 p > 0.05 -22.10 to 28.51 
  Column A vs Column C 
 
1.195 0.1313 p > 0.05 -24.11 to 26.50 
  Column B vs Column C 
 
-2.012 0.2210 p > 0.05   -27.32 to 23.29 
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Table 5.3  Volume fraction (%) of bone (minerlaized bone plus osteoid) and 
cartilage in the ossicles induced with 75ugTGF-3/Matrigel® and transplanted to 
periodontal defects.   The ossicles are similar in bone volume and neither contain 
residual carrier matrix.   
 
 
Volume Fraction (%) of Transplanted 75ugTGF-3/Matrigel Ossicles 
 
 Animal 1 Animal 2 Animal 3 Animal 4 
 
Bone 
 
43.7 - 38.2 - 
Mineralized 
Bone 
28.0 - 24.2 - 
Osteoid 15.7 - 14.0 - 
 
Cartilage 6.7 - 11.0 - 
 
Matrix 0.0 - 0.0 - 
 
 
 
Table 5.4  Volume fraction (%) of bone (mineralized bone plus osteoid) and 
carrier matrix of 2.5 µg TGF-3/25 µg rhOP-1/ICBM ossicles transplanted to 
periodontal defects.   The ossicle from Animal 4 consists of less osteogenic 
material and more carrier matrix than the ossicle harvest from Animal 2.  
  
 
Volume Fraction (%) of Transplanted  
2.5ugTGF-3/OP-1/ICBM Ossicles 
 
 Animal 1 
 
Animal 2 Animal 3 Animal 4 
Bone - 31.2 - 21.7 
 
Mineralized 
Bone 
- 25.0 - 13.2 
Osteoid - 6.2 - 8.5 
 
Cartilage - 0.0 - 0.0 
 
Matrix - 8.0 - 28.5 
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Table 5.5  Volume fraction (%) of bone (mineralized bone plus osteoid), cartilage 
and residual carrier matrix of ossicles not transplanted to periodontal sites. 
 
 
Volume fraction (%) of Non-Transplanted Ossicles 
 
Animal 1 Animal 2 Animal 3 Animal 4  
 
 
Type of Ossicle 
 
1.5µg  
TGF-3/ 
OP-1/ 
ICBM 
 
 
- 
2.5µg 
TGF-3/ 
OP-1/ 
ICBM 
 
1.5µg  
TGF-3/ 
OP-1/ 
ICBM 
 
 
- 
Bone 
 
32.7 - 37.5 46.7 - 
Mineralized 
Bone 
18.5 - 24.7 31.7 - 
Osteoid 
 
14.2 - 12.7 15.0 - 
Cartilage  
 
0 - 5.0 5.5 - 
Matrix 
 
5.2 - 2.0 0 - 
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5.2    Periodontal Implants 
 
5.2.1 Post-operative Observations 
 
Periodontal healing was uneventful in all four animals, but with mild inflammation 
in the immediate areas surrounding surgical sites (Figures 5.6 and 5.7). 
 
 
 
Figure 5.6  First and second maxillary molars, showing periodontal healing, sixty 
days post-implantation, exhibiting areas of mild inflammation (green arrows). 
 
 
 
 
 
Figure 5.7  First and second mandibular molars, showing periodontal healing, 
sixty days post-implantation, exhibiting areas of mild inflammation (green arrows). 
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 5.2.2   Radiographic Observations 
 
Radiographs taken at the time of surgery (Figure 5.8A) and again at harvest 
showed regeneration of alveolar bone in experimental specimens (Figure 5.8B) 
compared with little or no regeneration within the control defects implanted with 
Matrigel® carrier (Figure 5.9). 
  
 A      B 
Figure 5.8  Radiographs of mandibular defects implanted with rhTGF-3 plus 
muscle in Matrigel® before (A) and after (B) healing.  White arrows indicate 
notches at base of defects;  yellow arrows (B) indicate height of bone after sixty 
day healing period. 
 
 
                                        
 A                                                 B 
Figure 5.9  Radiographs of mandibular defects implanted with Matrigel® alone, 
before (A) and after (B) healing, showing little or no regeneration within the 
defects.  White arrows indicate notches at base of defects;  yellow arrows (B) 
indicate height of bone after sixty day healing period. 
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5.2.3 Histological Observations 
 
5.2.3.1   Matrigel® Control 
 
Histological sections of Matrigel® as control demonstrated partial healing (Figure 
5.10).  There was an abundance of fibrous tissue which extended to the coronal 
area of the furcation defect, with limited insertion of collagenous fibres.  The 
periodontal ligament consisted of areas sparsely populated with collagenous fibres, 
some of which were organized parallel to the cementum (Figure 5.11A).  This was 
in sharp contrast to the well-developed periodontal ligament situated immediately 
apical to the notched area (Figure 5.11B). 
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Figure 5.10  Matrigel® control specimen:  Photomicrograph showing periodontal 
tissue regeneration in a control specimen, 1.25x magnification.  Arrows indicate 
the notches made at time of implantation.  Modified Goldner’s stain. 
                               
       
                                                      
           
    A                                                 B 
 
Figure 5.11  Matrigel® control specimen:  Photomicrograph of new periodontal 
ligament in furcation defect area coronal to the notch (A) showing poorly 
organized periodontal ligament fibres arranged between cementum and alveolar 
bone, 20x magnification.  In the same specimen, the area apical to the notch (B) 
shows Sharpey’s fibres with good insertion, 20x magnification.  Modified 
Goldner’s stain.  Yellow arrows indicate cementum, green arrows indicate 
periodontal ligament fibres and black arrows indicate alveolar bone.  
 66
 
5.2.3.2 rhTGF-3 with Matrigel® carrier 
 
Histological sections showed evidence of newly formed alveolar bone (Figure 
5.12), new periodontal ligament and new cementum (Figure 5.13) within the defect 
areas. The new alveolar bone was arranged in a more compact manner than that of 
the apical residual alveolar bone (Figure 5.12).   The new periodontal ligament was 
highly vascularized with well-demarcated Sharpey’s fibres (Figure 5.13).  High 
power examination of the sections showed a repetitive pattern of capillary 
sprouting in close contact with the periodontal ligament fibres originating from the 
newly formed alveolar bone (Figure 5.13).  The arrangement of Sharpey’s fibres 
appeared to be governed by the position of the capillaries demonstrating a 
‘buttonhole’ effect along the edge of the newly formed alveolar bone.  This feature 
was particularly prominent in histology tissue of periodontal regeneration by 
rhTGF-3 in Matrigel®. 
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Figure 5.12  Periodontal tissue regeneration by rhTGF-3 with Matrigel® carrier:  
Photomicrograph of periodontal healing within furcation defect using rhTGF-3 in 
Matrigel® as carrier, 1.25x magnification.  Arrows indicate the notches made at 
time of implantation.  Modified Goldner’s stain. 
 
 
 
 
Figure 5.13  Periodontal tissue regeneration by rhTGF-3 with Matrigel® carrier:  
Histological section showing new periodontal ligament with repetitive pattern of 
capillaries along edge of alveolar bone (black arrows) and well-defined insertion of 
Sharpey’s fibres (white arrows), 40x magnification.  Modified Goldner’s stain. 
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5.2.3.3 rhTGF-3 plus muscle tissue implants with Matrigel® carrier 
 
Histological sections showed the presence of newly formed alveolar bone (Figure 
5.14) with new cellular cementum (Figure 5.15) and new, well-vascularized, 
periodontal ligament with Sharpey’s fibres (Figure 5.16).  The new alveolar bone 
appeared to be well distributed within the notched areas, extending from the apical 
notches to the coronal area of the furcation defects (Figure 5.14).  The new 
periodontal ligament exhibited highly organized collagenous fibres with functional 
insertion of Sharpey’s fibres into both new alveolar bone (Figures 5.17) and new 
cementum (Figure 5.18).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 69
 
 
 
  
   
     
  
Figure 5.14  Periodontal tissue regeneration by rhTGF-3 plus muscle tissue with 
Matrigel® carrier:  Photomicrographs showing newly formed alveolar bone within 
notched areas of furcation defects, 1.25x magnification.  Arrows indicate the 
notches made at time of implantation.  Modified Goldner’s stain. 
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Figure 5.15  Periodontal tissue regeneration by rhTGF-3 plus muscle tissue with 
Matrigel® carrier: Histological section showing new alveolar bone with osteoid, 
periodontal ligament, and cellular cementum, 10x magnification.  Modified 
Goldner’s stain. 
 
 
 
 
 
Figure 5.16 Periodontal tissue regeneration by rhTGF-3 plus muscle tissue with 
Matrigel® carrier: Histological section showing new alveolar bone with osteoid, 
periodontal ligament with prominent insertion of Sharpey’s fibres, and cellular 
cementum, 20x magnification.  Modified Goldner’s stain.  
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Figure 5.17  Periodontal tissue regeneration by rhTGF-3 plus muscle tissue with 
Matrigel® carrier: Histological section showing new periodontal ligament with 
insertion of Sharpey’s fibres into newly formed alveolar bone, 40x magnification.  
Modified Goldner’s stain. 
 
 
Figure 5.18  Periodontal tissue regeneration by rhTGF-3 plus muscle tissue with 
Matrigel® carrier: Histological section showing new periodontal ligament with 
vascularization and insertion of Sharpey’s fibres into new cellular cementum, 40x 
magnification.  Modified Goldner’s stain. 
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5.2.3.4   75µg rhTGF-3/Matrigel®-Induced Autogenous Bone  
 
Histological examination of the periodontal defects implanted with 75µg rhTGF-
3/Matrigel®-induced autogenous bone material showed new alveolar bone 
extending into the coronal area within the furcation defect with no separation 
between the residual alveolar bone and the newly generated bone.  One furcation 
defect showed osteogenic invasion of the pulp cavity (Figure 5.19), possibly due to 
damage to the dentinal area during the surgical creation of the periodontal defects.  
The new cementum appeared to be cellular (Figure 5.20) with a newly formed 
collagenous matrix of cementoid into which the new collagenous fibres were 
inserted (Figure 5.21).  The new periodontal ligament appeared to be well 
vascularized with an abundance of well-organized Sharpey’s fibres. In one defect 
there was a small area of ankylosis situated at the coronal margin of the defect 
(Figure 5.22).   
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Figure 5.19   Periodontal tissue regeneration by autogenous bone (75 µg rhTGF-
3/Matrigel® ossicle): Photomicrograph, 1.25x magnification, showing newly 
formed alveolar bone within furcation defect by rhTGF-3/Matrigel® ossicle.  
Arrow indicates osteogenic invasion of the pulp cavity.   
        
 
 
Figure 5.20  Periodontal tissue regeneration by autogenous bone (75 µg rhTGF-
3/Matrigel® ossicle): Histological section showing new alveolar bone, new 
periodontal ligament and new cellular cementum within the notched area of the 
defect, 10x magnification.  Modified Goldner’s stain. 
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Figure 5.21  Periodontal tissue regeneration by autogenous bone (75 µg rhTGF-
3/Matrigel® ossicle): Histological section showing insertion of Sharpey’s fibres 
into cementoid matrix of cementum, 40x magnification.  Modified Goldner’s stain. 
 
 
 
 
 
Figure 5.22  Periodontal tissue regeneration by autogenous bone (75 µg rhTGF-
3/Matrigel® ossicle): Histological section showing ankylosis within furcation 
defect at coronal margin, 10x magnification.  Modified Goldner’s stain.  
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5.2.3.5 2.5 µg rhTGF-3/25 µg rhOP-1/ICBM-Induced Autogenous Bone 
   
Histological examination of periodontal defects implanted with 2.5 µg rhTGF-
3/25 µg rhOP-1/ICBM-induced autogenous bone material showed incomplete 
regeneration of new alveolar bone (Figure 5.23), with new cementum and highly 
vascularized periodontal ligament with insertion of Sharpey’s fibres (Figure 5.24). 
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Figure 5.23  Periodontal tissue regeneration by autogenous bone (2.5 µg rhTGF-
3/25µg rhOP-1/ICBM ossicle):  Photomicrograph, 1.25x magnification, showing 
newly formed alveolar bone within furcation defects by 2.5 µg rhTGF-3/25 µg 
rhOP-1/ICBM ossicle.  Arrows indicate notches made at time of surgery. 
 
                          
  
 
 
 
Figure 5.24 Periodontal tissue regeneration by autogenous bone (2.5 µg TGF-
3/25 µg OP-1/ICBM ossicle):  Histological section showing new periodontal 
ligament with insertion of Sharpey’s fibres, 40x magnification.  Modified 
Goldner’s stain. 
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5.2.3 Histomorphometric Analysis 
 
Area (%) 
Figure 5.25 and Table 5.6 show the area of regenerated alveolar bone by the five 
implant variables.  Values are expressed as a percentage of the total defect size.  
TGF-β3/muscle (58.9 ± 3.2%) and Matrigel®-based autogenous bone (64.9 ± 
9.4%)  implants regenerated the most alveolar bone compared to the control 
(31.3% ± 9.1).   
 
Linear Measurements (mm) 
Table 5.7 gives the linear measurements (mm) in mean values including SEM for 
the height of the defect from the notch to the fornix of the furcation (N-F), the 
height of the new cementum (N-C) and new alveolar bone (N-AB), as regenerated 
by each of the five implant types for both mesial and distal root surfaces.  There 
were no significant differences (p > 0.05) between the defects (N-F), however 
significant differences were computed by Dunnett’s Multiple Comparison Test for 
notch to cementum (N-C, distal) (p < 0.05) for control versus TGF-β3/muscle, as 
well as the notch to alveolar bone height (N-AB, mesial) for control versus TGF-
β3/muscle (p < 0.05).  N-AB distal values for control versus TGF-β3/muscle and 
control versus  Matrigel®-based autogenous bone showed a significant difference 
(p < 0.01). 
 
Volume (%) 
Figure 5.26 and Table 5.8 show the results for histomorphometric analysis by the 
point counting technique (Parfitt, 1983) within the treated periodontal defects.  The 
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mean values (%) of alveolar bone regenerated by the five implant variables are 
divided into bone, mineralized bone and osteoid (Table 5.8).  Standard errors of the 
mean (SEM) have been included in the analysis.  Alveolar bone regenerated by 
Matrigel®-based autogenous bone (53.1 ± 4.9%) showed a significant difference  
(p < 0.05) compared to the control (30.3 ± 5.4%).  There was no significant 
difference (p > 0.05) between the other variables as shown by Dunnett’s Multiple 
Comparison Test (Table 5.9), which compares control group to experimental 
groups. 
 
An animal response comparison was performed by measuring the amount of 
alveolar bone regenerated within the periodontal defects by each animal, 
irrespective of implant type.  Figure 5.27 and Table 5.10 show that there was very 
little variation between Animals 1, 2 and 3.  However Animal 4 displayed a 
distinct lack of regenerative capabilities in comparison.  Table 5.10 gives the mean 
and SEM values (%) of alveolar bone regenerated by each animal.  The highest 
percentage of alveolar bone was regenerated by Animal 1 (51.6 ± 4.1%) and the 
lowest by Animal 4 (17.3 ± 2.2%);  n represents the number of defects per animal.  
Bonferroni’s Multiple Comparison Test (Table 5.11) compared the alveolar bone 
regenerated in each of the four animals.  Animals 1, 2 and 3 were all significantly 
different from Animal 4 (p < 0.001). 
 
The surgical implant designs for Animals 2 and 4 were alike (Figure 4.11, Table 
4.7 and Figure 4.12, Table 4.8 respectively) and should therefore have shown 
similar bone regeneration values.  Figure 5.28 and Table 5.12 compare the alveolar 
bone regenerated by TGF-3 in Matrigel® implants in each animal and show that 
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Animals 2 and 4 are far from similar.  The alveolar bone response by Animal 2 
(52.1 ± 7.6%) is almost four times that of Animal 4 (14.1 ± 0.8%).  Figure 5.29 
and Table 5.13 compare the alveolar bone regenerated by the 2.5 µg TGF-3/25 µg 
OP-1/ICBM ossicles.  The alveolar bone response by Animal 2 is 59.7 ± 5.9% 
while Animal 4 responded with 19.8 ± 0.9%.  
 
Data gathered by the point counting technique (Parfitt, 1983) was used to compare 
the total amount of alveolar bone regenerated in all mandibular defects (teeth 36, 
37, 46 and 47) compared to all maxillary defects (teeth 16, 17, 26 and 27).  Figure 
5.30 and Table 5.14 showed that there was no statistical difference between 
maxillary (43.3 ± 3.9%) and mandibular (41.2% ± 4.9%) defects.   
 
The same data was used to analyze the difference in bone regeneration between 
first molars (teeth 16, 26, 36 and 46) and second molars (teeth 17, 27, 37, and 47).  
Figure 5.31 and Table 5.15 demonstrate no significant difference in bone 
regeneration between first (38.3% ± 4.4%) and second (46.2% ± 4.2%) molars.  
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 Area of New Alveolar Bone 
  Control 
  TGFβ3  TGFβ3/Mus       AB/Mat     AB/ICBM0
25
50
75
Control
TGFβ3
TGFβ3/Muscle
AB/Matrigel
AB/ICBM
 
  %  Bone 
 
Key 
Control Matrigel® alone 
 
TGF3 rhTGF-3 in Matrigel® carrier  
  
TGF3/Mus  rhTGF-3 and muscle tissue in Matrigel® carrier 
   
AB/Mat  
 
Matrigel®-based autogenous bone ossicle (75 µg rhTGF-β3 in Matrigel® carrier)  
 
AB/ICBM  ICBM-based autogenous bone ossicle (2.5 µg rhTGF-β3/25 µg rhOP-1/ICBM)  
 
 
Figure 5.25 Area of new alveolar bone compared to total defect as regenerated by 
the five implant variables.  Values are expressed in percentage (%).  
 
 
 
 
 
 
 
 
Table 5.6  Area of new alveolar bone compared to total defect size.  Values are 
expressed in percentage (%);  n indicates the number of defects per implant type. 
 
 
 
Control 
 
SEM 
 
n 
 
TGFβ3 
 
SEM 
 
n 
 
TGFβ3/ 
Muscle 
 
SEM 
 
n 
 
AB/ 
Matrigel 
 
SEM 
 
n 
 
AB/ 
ICBM 
 
SEM 
 
n 
 
 
 
31.3 
 
± 9.1 
 
8 
 
45.5 
 
± 28.0 
 
4 
 
58.9 
 
± 3.2 
 
8 
 
64.9 
 
± 9.4 
 
8 
 
40.0 
 
± 1.9 
 
4 
 
 81 
Table 5.7  Histometric analysis of periodontal tissue regeneration in 32 furcation defects.  Values (in mm) are given as mean ± SEM;  
n indicates the number of defects.   
N: apical border of the notches on the mesial and distal roots surfaces; F: fornix of the furcation defect;   
C: cementum;   AB: alveolar bone.   
There was no significant difference detected by Dunnett’s Multiple Comparison Test (p > 0.05) for  
N-F (mesial and distal values), or N-C (mesial).  
Significant differences were noted for:   
N-C (distal) control versus TGF-β3/Muscle implant (p < 0.05);   N-AB (mesial) control versus TGF-β3/Muscle implant (p < 0.05),  
N-AB (distal) control versus TGF-β3/Muscle implant (p < 0.01); N-AB (distal) control versus AB/Matrigel® (p < 0.01).  
 
 
 
 
 
Control 
 
SEM 
 
n 
 
TGF-3 
 
SEM 
 
n 
 
TGF-3/ 
Muscle 
 
SEM 
 
n 
 
AB/ 
Matrigel 
 
SEM 
 
n 
 
AB/ 
ICBM 
 
SEM 
 
n 
 
 
Mesial                
                
N-F 6.0 mm ± 0.3 8 5.9 mm ± 0.1 4 6.2 mm ± 0.1 8 5.5 mm ± 0.4 8 5.2 mm ± 0.4 4 
N-C 4.5 mm ± 0.7 8 3.8 mm ± 0.9 4 6.1 mm ± 0.2 8 5.3 mm ± 0.4 8 5.1 mm ± 0.4 4 
N-AB 2.9 mm ± 0.6 8 2.8 mm ± 0.9 4 4.8 mm ± 0.3 8 4.6 mm ± 0.4 8 2.6 mm ± 0.9 4 
                
Distal                
                
N-F 6.0 mm ± 0.2 8 5.9 mm ± 0.3 4 6.5 mm ± 0.1 8 5.8 mm ± 0.4 8 5.9 mm ± 0.4 4 
N-C 3.7 mm ± 0.7 8 3.5 mm ± 0.6 4 6.1 mm ± 0.4 8 5.2 mm ± 0.5 8 4.8 mm ± 0.8 4 
N-AB 2.3 mm ± 0.4 8 2.8 mm ± 0.8 4 4.7 mm ± 0.3 8 4.9 mm ± 0.5 8 2.8 mm ± 1.2 4 
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     % Bone 
 
 
 
Key 
 
Control Matrigel® alone 
 
TGF3 rhTGF-3 in Matrigel® carrier  
  
TGF3/Mus  rhTGF-3 and muscle tissue in Matrigel® carrier 
   
AB/Mat  
 
Matrigel®-based autogenous bone ossicle (75 µg rhTGF-β3 in Matrigel® carrier)  
 
AB/ICBM  ICBM-based autogenous bone ossicle (2.5 µg rhTGF-β3/25 µg rhOP-1/ICBM)  
 
 
Figure 5.26  Distribution of alveolar bone (mineralized bone plus osteoid) as 
regenerated by each of the five variables.  Periodontal tissue regeneration by 
Matrigel®-based autogenous bone ossicle (75 µg rhTGF-β3/Matrigel® ossicle) 
yielded the most significant amount of alveolar bone (53.1 ± 4.9 %) when 
compared to the control (30.3 ± 5.4%) (p < 0.05).   
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Table 5.8  Volume fraction (%) of bone, i.e., mineralized bone (Md bone) plus 
osteoid, as regenerated by the five variables implanted in periodontal furcation 
defects.  Values are expressed as mean and standard error of the mean (SEM); n 
indicates the number of defects per implant variable.    
 
 
Control 
 
 
TGF-3 
 
TGF-3/Muscle 
 
AB/Matrigel 
 
AB/ICBM 
 
Mean 
 
    SEM 
 
n 
 
 Mean 
 
SEM 
 
n 
 
Mean 
 
SEM 
 
n 
 
  Mean 
 
SEM 
 
n 
 
Mean 
 
SEM 
 
n 
 
 
 
 
 
 
  
 
Bone 
 
 
30.3 
 
   ±  5.4 
 
 8 
 
 33.1 
 
±  11.4 
 
4 
 
49.3 
 
± 3.1 
 
8 
 
    53.1 
 
± 4.9 
 
8 
 
39.7 
 
± 11.8 
 
4 
 
  
 Md      
Bone 
 
24.7 
 
   ±  5.1 
 
 8 
 
 26.5 
 
±  10.1 
 
4 
 
35.9 
 
± 2.1 
 
8 
 
    38.1 
 
± 3.9 
 
8 
 
30.4 
 
± 9.9 
 
4 
 
 
Osteoid 
 
 
5.5 
 
   ±  1.1 
 
 8 
 
 6.6 
 
±  1.2 
 
4 
 
13.3 
 
± 1.5 
 
8 
 
    14.8 
 
± 1.5 
 
8 
 
9.3 
 
± 2.0 
 
4 
 
 
 
 
 
 
Table 5.9  Dunnett’s Multiple Comparison Test compares the control group 
(Column A) with the experimental groups:   
rhTGF-3/Matrigel®    (Column B),  
rhTGF-3 and muscle tissue in Matrigel® carrier  (Column C),   
Matrigel®-based autogenous bone   (Column D),  
ICBM-based autogenous bone   (Column E).   
 
Control (Column A) compared to Matrigel®-based autogenous bone (Column D) 
showed a significant difference (p < 0.05).  
 
 
Dunnett's Multiple 
Comparison Test 
 
 
Mean Diff. 
 
q 
 
p value 
 
95% CI of diff 
Column A vs Column B 
 
-2.800 0.2893 p > 0.05 -27.92 to 22.32 
Column A vs Column C 
 
-19.00 2.404 p > 0.05 -39.51 to 1.509 
Column A vs Column D 
 
-22.80 2.885 p < 0.05 -43.31 to -2.291 
Column A vs Column E 
 
-9.400 0.9711 p > 0.05 -34.52 to 15.72 
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Figure 5.27  Volume (%) of alveolar bone regenerated by each animal.  The 
amount of alveolar bone regenerated by Animals 1, 2 and 3 is much greater than 
that regenerated by Animal 4.  
 
 
Table 5.10   Alveolar bone regenerated within the periodontal furcation defect of 
each animal irrespective of implant type used.  Animal 4 shows a distinct lack of 
regenerative capabilities compared to Animals 1, 2 and 3.  n is the number of 
defects per animal.     
 
Animal 
 
 
Total Alveolar Bone 
Regenerated (% mean) 
 
SEM 
 
n 
Animal 1 51.6 ± 4.1 8 
Animal 2 49.3 ± 3.5 8 
Animal 3 50.7 ± 4.1 8 
Animal 4 17.4 ± 2.6 8 
 
Comparison of Alveolar Bone
Regeneration in Animals 1 to 4
Animal 1 Animal 2 Animal 3 Animal 40
25
50
75
 
   % Bone  
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Table 5.11 Bonferroni’s Multiple Comparison Test compares the alveolar bone 
regenerated in each of the four animals.  There is a significant difference between 
Animal 1 and Animal 4 (p < 0.001), Animal 2 and Animal 4 (p < 0.001), and Animal 
3 and Animal 4 (p < 0.001). 
 
 
Bonferroni's Multiple Comparison Test 
 
 
Mean            
Diff. 
 
    t 
 
   p value 
Animal 1 vs Animal 2 Column A vs Column B 2.337 0.4493 p > 0.05 
Animal 1 vs Animal 3 Column A vs Column C 0.9000 0.1730 p > 0.05 
Animal 1 vs Animal 4 Column A vs Column D 34.24 6.580 p< 0.001 
Animal 2 vs Animal 3 Column B vs Column C -1.438 0.2763 p > 0.05 
Animal 2 vs Animal 4 Column B vs Column D 31.90 6.131 p < 0.001 
Animal 3 vs Animal 4 Column C vs Column D 33.34 6.408 p < 0.001 
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Figure 5.28  Comparison of the amount of alveolar bone regenerated in Animals 2 
and 4 by rhTGF-3/Matrigel® implants in periodontal defects. 
      
 
 
 
 
 
 
 
 
Table 5.12  Comparison of amount of alveolar bone regenerated in periodontal 
defects in Animals 2 and 4 by rhTGF-3 in Matrigel®.   
 
 
Alveolar Bone Regenerated in Animals 2 and 4 by rhTGF-3 in Matrigel® 
 
  
Bone (% mean) 
 
 
SEM 
 
n 
Animal 2 52.1 ± 7.6 2 
Animal 4 14.1 ± 0.8 2 
 Amount of Alveolar Bone 
Regenerated in Animals 2 and 4 
by rhTGF-3 in Matrigel   
 Animal 2   Animal 4
0
25 
75 
       % Bone
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 Amount of Alveolar Bone
 
Regenerated in Animals 2 and 4
 
by ICBM-based Ossicles
 
Animal 2 Animal 4 0 
25 
50 
75 
% Bone 
 
 
Figure 5.29  Comparison of amount of alveolar bone regenerated in periodontal 
defects in Animals 2 and 4 by 2.5 µg TGF-3/25 µg rhOP-1/ICBM ossicles. 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.13  Comparison of amount of alveolar bone regenerated in periodontal 
defects in Animals 2 and 4 by 2.5 µg TGF-3/25 µg rhOP-1/ICBM ossicles.    
 
 
Alveolar Bone Regenerated in Animals 2 and 4  
by 2.5 µg rhTGF-3/25µg rhOP-1/ICBM Ossicles 
 
 
 
Bone (% mean) 
 
 
SEM 
 
n 
Animal 2 59.7 5.9 2 
 
Animal 4 19.8 0.9 2 
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Figure 5.30  Comparison of alveolar bone regenerated in mandibular and maxillary 
defects.   
 
 
 
 
 
 
Table 5.14  Comparison of total amount of alveolar bone regenerated in mandibular 
implants compared to maxillary implants.  There is no significant difference between 
mandibular (41.2 ± 3.9%) and maxillary (43.3 ± 4.9%) defects;  n indicates the 
number of defects. 
 
 
 
 
Site 
 
Total Alveolar 
Bone Regenerated 
(% mean) 
 
 
SEM 
 
 
 
n 
 
Mandibular 
Implants 
 
41.2 
 
± 3.9 
 
16 
Maxillary 
Implants 
 
43.3 
 
± 4.9 
 
16 
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  Amount of Alveolar Bone 
Regenerated in 1st and 2nd Molars 
 
  1st Molar    2nd Molar 0 
25 
50 
75 
      
  % Bone 
 
 
Figure 5.31  Volume (%) of alveolar bone regenerated in the first and second 
molars of the animals showing  that the difference was not statistically significant. 
 
 
 
 
 
 
 
 
Table 5.15  Comparison of  total amount of alveolar bone regenerated in first and 
second molars.  There is no statistical difference between first (38.3 ± 4.4%) and 
second (46.2 ± 4.2%) molars;  n indicates the number of molars. 
   
 
Site 
Total Alveolar 
Bone Regenerated 
(% mean) 
 
SEM 
 
 
n 
 
 
1st Molar 
 
38.3 
 
± 4.4 
 
16 
 
2nd Molar 
 
 
46.2 
 
 
± 4.2 
 
16 
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6. DISCUSSION 
 
 
The present study evaluated the healing potential of rhTGF-3 when implanted in 
Class II furcation defects of Papio ursinus, either by direct application of the 
morphogen to the defects, or by transplantation of TGF-3-induced autogenous 
bone.  Both methods have shown remarkable potential for the regeneration of 
alveolar bone, periodontal ligament and cementum within the exposed furcations. 
 
It was noted that in one animal (Animal 4) all treated furcation defects showed 
only a limited amount of tissue regeneration (Figure 5.27 and Table 5.10).  At the 
time of surgery it became apparent to the surgical team that the animal was 
somewhat older than the others.  The gingivae appeared to be friable, making 
suturing difficult.  However, post-operative healing was uneventful with evidence 
of only mild inflammation.  Induced autogenous bone harvested from the 
heterotopic implants appeared to be adequate, but upon histological examination it 
was noted that the trabecular bone was sparsely distributed with an abundance of 
residual carrier matrix (Figure 5.4 and Table 5.4).  Differences in the induction of 
both heterotopic bone and periodontal tissue regeneration may be ascribed to 
animal-to-animal variation and, to date, are neither quantifiable nor 
mechanistically explained.  However, in vitro studies on rodent bone marrow stem 
cells by Quarto et al. (1995) showed that age is related to a deficit of 
osteoprogenitor cells.  Fleet et al. (1996) demonstrated that the activity of an 
osteoinductive protein is significantly compromised by advancing age but that this 
could be partially reversed by increasing the amount of growth factor at the 
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implant site.    With these observations in mind, it would appear that enthusiastic 
response to TGF-3 might be regulated by age.   
 
The delivery system of choice for this study was Matrigel® matrix as it has several 
attractive qualities for use in a periodontal study.  It is a user-friendly, injectable, 
thermodynamic material, which gels at body temperature, forming a three-
dimensional scaffold.  At 4oC, Matrigel® is liquid which allows for the 
incorporation and even distribution of growth factors.  By means of a syringe, the 
Matrigel® matrix together with the soluble molecular signal can be placed 
accurately within the defect during surgery.  The gelled consistency of the material 
conforms to the shape of the defect giving better integration with the surrounding 
tissue.    Matrigel® matrix contains several growth factors including TGF-.  
However, a more purified product is available in the form of Growth factor 
reduced (GFR) Matrigel® matrix, in which the quantities of the growth factors are 
reduced, with TGF- content at a minimal value of 1.7ng/ml.  GFR Matrigel® was 
used for this study so as to allow for fair assessment of the added TGF- isoform 
performance.   
 
Furcation defects implanted with GFR Matrigel® showed partial bony regeneration 
(Figure 5.10) with minimal cementogenesis.  The collagenous fibres within the 
periodontal ligament were arranged parallel to the cementum (Figure 5.11A) and 
this lack of orientation of one of the pivotal tissues of periodontal healing, together 
with the reduced amount of alveolar bone regenerated, was a clear indication that 
GFR Matrigel® on its own is not capable of inducing acceptable periodontal tissue 
regeneration.  
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Experimental studies in dogs using TGF-1 (Wikesjö et al., 1998; Tatakis et al., 
2000) demonstrated little or no alveolar bone and cementum regeneration.  To 
date, no studies have been conducted using TGF-3 in periodontal regeneration, let 
alone the incorporation of this morphogen in periodontal defects of the non-human 
primate Papio ursinus.  Coelho et al. (2003; 2004) maintained that TGF-3, as the 
main isoform in intramembranous bone such as the mandible, should be of 
significant benefit when employed in the repair of mandibular defects as it 
demonstrated a high capacity for mesenchymal cell stimulation of angiogenesis 
and/or osteogenesis.  The angiogenic potency of TGF-3 was described more than 
a decade ago by Merwin et al. (1991) and Cox et al. (1994; 1995) and the 
osteogenic capabilities of TGF-3, within soft tissue implants, was noted more 
recently by Ripamonti et al. (2004b), highlighting the evidence that angiogenesis is 
a prerequisite for bone formation (Trueta, 1963).   
 
The most prominent feature of periodontal tissue regeneration within the defects 
implanted with rhTGF-3 in Matrigel® matrix was the striking vascularization seen 
in the periodontal ligament (Figure 5.13).  The formation of multiple capillaries 
along the edge of the alveolar bone appeared to preside over the arrangement and 
insertion of the Sharpey’s fibres emphasizing Trueta’s hypothesis that 
vascularization is the forerunner of osteogenesis.   In this study, periodontal defects 
implanted with rhTGF-3 in Matrigel® showed virtually complete healing (Figure 
5.12) in two of the four implant sites.  However, the amount of alveolar bone 
regenerated by rhTGF-3 on its own was less significant (Figure 5.26) when 
compared to that of rhTGF-3/muscle and Matrigel®-based autogenous bone 
transplant (75 µg rhTGF-β3/Matrigel® ossicle).  This may not be a true reflection 
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of the regenerative capabilities of TGF-3 as two of the four furcation defects 
implanted with rhTGF-3 performed well with an average of 52.1 ± 7.6% alveolar 
bone regenerated (Figure 5.28 and Table 5.12).  The remaining two defects 
implanted with rhTGF-3 were those of Animal 4, which was a particularly poor 
respondent (Figure 5.28 and Table 5.12), and showed an average of 14.1 ± 0.8% 
alveolar bone regeneration.  Hypothetically, if Animal 4 had been as competent a 
respondent as Animal 2, it is possible that a different outcome for this study may 
have been reported with superlative periodontal regeneration induced by rhTGF-3 
in Matrigel®.  
 
Zacks and Sheff (1982) reported that nodules of cartilage and bone were induced in 
mouse limbs when implanted with minced skeletal muscle tissue.  The structures 
resembled bony outgrowths of cartilage-capped bone.   The TGF-beta isoform is 
site and tissue specific (Ripamonti et al., 1997; Duneas et al., 1998; Ripamonti et 
al., 2000), possibly due to the presence or absence of the required responding cells 
in various anatomical locations or the presence of inhibitory binding proteins 
(Nakao et al., 1997).   This phenomenon was initially noted in studies by 
Ripamonti et al., (1996b) when TGF-β1 showed only limited chondro-osteogenesis 
in calvarial sites but induced large heterotopic ossicles of endochondral bone 
within the rectus abdominis of non-human primates (Ripamonti et al., 1997; 
Duneas et al., 1998).  Subsequent studies carried out by Ripamonti et al. (2000), 
using high doses of rhTGF-2 in calvarial defects, demonstrated bone formation 
which was restricted to the pericranial region of the specimen, that is, new bone 
formed only along the muscle-lined periphery of the implant.  It is therefore 
possible that muscle contains the responding cells required for the initiation of 
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osteogenesis within certain bony sites.  Further studies by Ripamonti et al. 
(unpublished data) have demonstrated that muscle tissue, added to a bony defect 
site where TGF-beta isoforms are being employed, is beneficial in encouraging 
healing.  Studies performed by other researchers have shown that skeletal muscle 
tissue contains inducible osteoprogenitor cells which, when stimulated by 
morphogens, are capable of differentiating into osteoblasts (Lee et al., 2001; 
Turgeman et al., 2002; Lu et al., 2003; Corsi et al., 2004; Sun et al., 2005).   In this 
study, this concept was exploited by transplanting harvested muscle tissue (from 
the rectus abdominis muscle of the baboons), combined with rhTGF-3, to a 
periodontal site where superior regeneration of alveolar bone, cementum and 
periodontal ligament was elicited together with prominent vascularisation and the 
insertion of functionally oriented collagenous fibres (Figures 5.14 through 5.18).  
The formation of new cementum was particularly enhanced in defects implanted 
with rhTGF-3 and muscle (Table 5.7).  The quantity of new alveolar bone was 
significantly greater (p < 0.05) in defects implanted with rhTGF-3 and muscle 
than in control defects (Figures 5.25 and 5.26; Tables 5.6 and 5.8).  
 
Autogenous bone graft has for some time been the method of choice for enhancing 
biological repair within bony sites.  Experimental methods using growth factor-
induced prefabricated muscular flaps have been utilized for the manufacture of 
autogenous bone for the treatment of bony defects (Khouri et al., 1991; Alam et 
al., 2001; 2003; Abdelaal et al., 2004).  The graft material is harvested at an 
optimal time of growth and transplanted to a bony defect site.  The time period 
allowed for growth of autogenous bone is of critical importance.  If harvested too 
early, there may be no evidence of bony transformation and if harvested too late, 
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resorption may have taken place or the bone may be difficult to excise due to 
fusion with the surrounding tissue.  In addition, induced autogenous bone material 
that has been left for too long may be too hard to fragment prior to transplantation.  
Attempting to transplant larger fragments to an irregularly shaped defect site may 
be problematic.  In the present study, the original time period decided upon for 
heterotopic bone initiation was 30 days.  However, due to the unavailability of 
theatre facilities and the surgical team, the harvesting was postponed by ten days.  
Those ossicles which survived this prolonged period, contained an abundance of 
osteogenic material, consisting of trabecular bone covered by osteoid seams, which 
were populated by osteoblasts (Figures 5.2, 5.3 and 5.5; Table 5.1).  However, the 
loss of a large number of ossicles (Table 4.5), which had been detected earlier by 
palpation but not located during surgery on day 40, indicates that there are more 
factors than time period alone that need to be considered.  The fact that all low 
TGF-3 dose implants in Matrigel® carrier were resorbed (Table 4.5) may indicate 
that Matrigel® has a higher rate of resorption than ICBM and that for a time period 
exceeding 30 days (or possibly less), large doses of TGF-3 are indicated if a 
Matrigel® carrier is to be used.  The incorporation of the ICBM-based implants 
was originally meant for laboratory interest only but due to the failure of so many 
Matrigel®-based implants and in an effort to salvage this study, it became 
necessary to make use of the ICBM-based implants.  The addition of 25 µg rhOP-1 
to the implants appeared to have little influence on the time factor as some ossicles 
survived the 40-day implantation period while others did not.  An equal number of 
2.5 µg rhTGF-3/25 µg rhOP-1/ICBM ossicles and 1.5 µg rhTGF-3/25 µg rhOP-
1/ICBM ossicles survived (Table 4.5), possibly indicating that the OP-1 : TGF-3 
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ratio was within the optimal range for synergistic interaction when using ICBM as 
carrier but not so for Matrigel®. 
 
The Matrigel®-based endochondral ossicles which were transplanted to periodontal 
defects showed bony proliferation within furcation defects after the 60 day healing 
period resulting in dense areas of alveolar bone regeneration (Figure 5.19).  New 
cellular cementum (Figure 5.20) and new periodontal ligament with insertion of 
Sharpey’s fibres into a cementoid matrix (Figures 5.21) were noted within the 
defects.  A small area of ankylosis was seen in the coronal region of the furcation 
defect (Figure 5.22).  In this study, transplanted Matrigel®-based endochondral 
ossicles yielded the best results for periodontal tissue regeneration with a total 
bone volume of 53.1 ± 4.9% (Figure 5.26; Table 5.8) compared to control (30.3 ± 
5.4%). 
 
The heterotopic ossicles induced by the binary application of 2.5 µg rhTGF-3 and 
25 µg rhOP-1 with ICBM as carrier yielded the least bone volume (Figure 5.5 and 
Table 5.1).  This trend was perpetuated after transplantation to the periodontal 
furcation defects where incomplete alveolar bone regeneration was noted (Figure 
5.23).  The alveolar bone regenerated by the ICBM-based transplants (39.7 ± 
11.8%) showed no statistical difference compared to the control (30.3 ± 5.4%).  
Ironically, the two low-dose ossicles (1.5 µg rhTGF-3/25 µg rhOP-1/ICBM) that 
survived but were not transplanted, were the more viable of the two types of 
ICBM-based ossicles (Figure 5.5 and Table 5.1) with bone volumes of 39.7 ± 7.0% 
and 30.1 ± 4.5% for 1.5 µg rhTGF-3/25 µg rhOP-1/ICBM and 2.5 µg rhTGF-
3/25 µg rhOP-1/ICBM ossicles, respectively.  In fact, the low-dose ICBM 
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ossicles were more comparable with the Matrigel®-based ossicles than with each 
other (Figure 5.5 and Table 5.1). 
 
Measurements carried out by the point counting technique (Parfitt, 1983) revealed 
that there was no significant difference in periodontal tissue regeneration between 
mandibular and maxillary defects (Figure 5.30 and Table 5.14).  There was also no 
significant difference in periodontal tissue regeneration between defects of the first 
and second molars (Figure 5.31 and Table 5.15). 
 
There are limitations that need to be acknowledged regarding the present study.  
The negative impact of a poor respondent has far-reaching consequences, even 
more so when a study consists of too few animals and too many implant variables.  
Ideally, an experiment of this nature should have no more than four variables, 
including the control, implanted in each animal.  This would circumvent problems 
related to animal performance in that each animal would be host to the entire 
repertoire of implants to be used.  The second limitation of this study is the rapidity 
of bone formation and subsequent resorption of the heterotopically induced ossicle.  
Further studies are needed to pinpoint the correct time period for bone induction in 
the rectus abdominis by the various growth factors or combinations thereof.   
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7.  CONCLUSION 
  
 
This study, with a short-term observation period and only histological analysis as 
an evaluation parameter, indicates by morphology and histomorphometry, that 
rhTGF-3, delivered by Matrigel® as carrier, induces the key elements of 
periodontal tissue regeneration, namely, alveolar bone, periodontal ligament and 
cementum.  The addition of skeletal muscle from the rectus abdominis enhanced 
the periodontal tissue regeneration with increased cementum formation indicating 
that the harvested muscle tissue retained responding mesenchymal cells capable of 
transformation into the essential components of periodontal tissue regeneration 
upon application of exogenous rhTGF-3.  The innovative strategy of engineering 
heterotopic ossicles by the application of rhTGF-3 singly, or in combination with 
rhOP-1, was implemented, which allowed fragmented, induced heterotopic bone to 
be transplanted to surgically created periodontal defects and resulted in the 
induction periodontal tissue regeneration.  Within a clinical context, the rapid 
production of mineralized ossicles in the rectus abdominis by rhTGF-3 is a novel 
source of induced autogenous bone for transplantation, which may augment or 
eventually usurp bone graft material harvested from the iliac crest.   
 
This study in non-human primates is the first step in investigating the regenerative 
capabilities of rhTGF-3 in a periodontal application and the results achieved 
indicate that rhTGF-3 may be on the brink of therapeutic application. 
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9.  APPENDICES 
 
 
Appendix 1 
 
Dilutions  for  rhTGF-3  Doses 
 
 
 
Stock solution:  800 µg TGF-3 in 2000 µl 5 mM HCl 
 
(0.4 µg TGF-3 / µl HCl) 
 
 
Dilutions for doses: 
 
                       
125 µl stock solution used for: 
 
 
1875 µl stock solution used for: 
 
 
2.5  µg TGF-3 
 
 
1.5 µg TGF-3 
 
 
75 µg TGF-3 
 
50 µl HCl = 20 µg TGF-3 
plus 1550 µl HCl 
1600 µl = 20 µg TGF-3 
30 µl HCl = 12 µg TGF-3 
plus 1570 µl HCl 
1600 µl = 12 µg TGF-3 
 
1875 µl HCl = 750 µg TGF-3 
plus 125 µl HCl 
2000 µl = 750 µg TGF-3  
 
 
For an amount of 200 µl per dose: 
 
 
200 µl = 2.5 µg TGF-3 
 
 
 
200 µl = 1.5 µg TGF-3 
 
 
 
200 µl = 75 µg TGF-3 
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Appendix  2 
 
Preparation  of  OP-1  Solutions 
 
Preparation of rhOP-1 doses:   
 
A 600 µl stock solution of rhOP-1 in 5 mM HCl, containing 960 µg of rhOP-1 was 
available for use.  An amount of 0.625 µl of stock solution therefore contained 1 
µg rhOP-1.  For the required dose of 25 µg rhOP-1, an amount of 15.625 µl of 
stock solution was be used.  Accurate measurement was achieved by using a 2 – 20 
µl Nichipet autoclavable micropipette.   
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Appendix  3 
 
Preparation  of  Insoluble  Collagenous  Bone Matrix (ICBM) 
 
1. Diaphyseal segments of baboon tibia and femur were dehydrated using 
absolute alcohol and treated with diethyl ether to remove fat. 
2. The dehydrated bone segments were then pulverized under liquid nitrogen by 
means of an industrial crusher from the Geology Department, University of 
the Witwatersrand, sieved through 74 – 420 micron meshes and only particles 
within this range collected. 
3. The powder was demineralized overnight under cold conditions using 0.5 N 
hydrochloric acid (pH 2.0), neutralized with 50 mM Tris-hydrochloric acid 
(pH 7.4) and extracted with a solution of 4 M guanidinium hydrochloric acid 
in 50 mM Tris (pH 7.4) containing protease inhibitors (100 mM α-amino-n-
caproic acid, 5 mM benzamidine HCl, 0.5 mM phenyl methasulphonyl 
fluoride and 5 mM N-ethyl maleimide). 
4. The resultant ICBM was washed with 0.5 M Tris (pH 7.4) and lyophilized 
overnight. 
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Appendix  4 
 
Matrigel®-based  Implants     
           
A constant volume of 200 µl was used throughout the experiment for the Matrigel® 
doses.  As per manufacturer’s specifications, in order to maintain a gelled 
consistency, a dilution not exceeding 1:3 was used.  Therefore, 200 µl containing 
the relevant rhTGF-β3 dose was added to 400 µl Matrigel® carrier, resulting in an 
implant device of 600 µl to be placed in the predetermined heterotopic or 
periodontal site. 
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Appendix  5 
 
ICBM-based  Implants 
  
Pellets designed for heterotopic sites were impregnated with rhOP-1 and rhTGF-β3 
proteins and were made as follows: 
 
1. Using sterile 15 ml polypropylene centrifuge tubes, add the desired protein 
combination to 100 mg ICBM.  
2. Leave to stand for a few minutes to allow precipitation of proteins into the 
ICBM. 
3. Add 2mg chondroitin sulphate and 2mg baboon Type 1 collagen and vortex. 
4. Wash with 2 to 3 volumes of pre-chilled absolute ethanol, centrifuge at 2500 
rpm for 15 minutes (i.e. 3 x 5 minutes with chilling at -70°C at 10 to 15 minute 
intervals).   
5. Decant the absolute ethanol supernatant. 
6. Invert the tubes briefly on absorbent paper towel to drain. 
7. Lyophilize the pellets overnight. 
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Appendix  6 
 
Processing  Schedule  for  K-Plast  Resin  Embedding 
 
70%  Alcohol       24 hours 
80% Alcohol                    24 hours 
96% Alcohol       24 hours 
96% Alcohol       24 hours 
100% Alcohol       24 hours 
100% Alcohol       24 hours 
100%  Alcohol       24 hours 
100% Alcohol       24 hours 
Toluene         48 hours 
Toluene         48 hours 
Infiltrate under vacuum in K-Plast resin     4  weeks 
Embed in K-Plast resin   
Infiltration Solution: 
K-Plast Infiltration solution A      90 ml 
K-Plast Infiltration solution B                 10 ml  
Embedding Solution: 
K-Plast Infiltration solution A      90 ml 
K-Plast Infiltration solution B      10 ml 
K-Plast Initiator        1.0 g 
Supplier: 
Medis Weber, Floesser Weg 10, D-35418 Buseck, Germany 
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Appendix  7 
 
Modified  Goldner’s  Trichrome  Staining  Method 
(Modified from Bancroft and Stevens, 1996) 
 
1. Stain sections in Stable Iron Haematoxylin for 20 minutes.  Wash in running 
tap water. 
2. Differentiate in acid alcohol for 1 – 2 minutes.  Wash and blue in running tap 
water for10 minutes. 
3. Stain sections in Ponceau Fuchsin for 45 minutes.  Wash briefly in water and 
rinse in 1% acetic acid 
4. Differentiate sections in Orange G for 13 minutes (time may vary with age of 
solution).  Wash briefly in water and rinse in 1% acetic acid. 
5. Stain in 2% Methyl Blue for 10 minutes.  Wash well in tap water and rinse in 
1% acetic acid.  Drain well on paper towel. 
6. Rinse sections in 2 changes of 96% alcohol and 2 changes of absolute alcohol. 
7. Dehydrate sections in 2 more changes of absolute alcohol of 30 minutes each. 
8. Place sections on slide and trim away excess resin with a scalpel blade. 
9. Coverslip using Entellan mounting medium. 
10. Place weight on top of mounted slides and leave for 48 hours to flatten 
sections. 
Results: 
Mineralized bone – blue 
Osteoid – orange/red 
Nuclei – blue/black 
